pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLC10.18093/0869-0189-2022-32-6-806-833pulmo-4155Research ArticleКЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИCLINICAL GUIDELINESСаркоидоз: федеральные клинические рекомендации по диагностике и лечениюSarcoidosis: federal clinical guidelines for diagnosis and treatmenthttps://orcid.org/0000-0002-6808-5528ЧучалинА. Г.ChuchalinA. G.

Чучалин Александр Григорьевич – доктор медицинских наук, профессор, академик  Российской  академии  наук, заведующий кафедрой  госпитальной терапии педиатрического факультета РНИМУ  им. Н.И. Пирогова МЗ РФ; председатель  правления Российского респираторного общества.

117997, Москва, ул. Островитянова, 1

тел.: (499) 780-08-50

SPIN-код: 7742-2054

Alexander G. Chuchalin - Doctor of Medicine, Professor, Academician of Russian Academy of Sciences, Head of Department of Hospital Internal Medicine, Pediatric  Faculty,  Pirogov Russian National  Research  Medical  University (Pirogov Medical University),  Healthcare Ministry of Russia; Chairman of the Executive Board of Russian Respiratory Society.

Ostrovityanova ul. 1, Moscow, 117997

tel.: (499) 780-08-50

SPIN: 7742-2054

pulmomoskva@mail.ruhttps://orcid.org/0000-0002-5999-2150АвдеевС. Н.AvdeevS. N.

Авдеев Сергей Николаевич – доктор медицинских наук, профессор, академик  Российской академии наук, заведующий кафедрой пульмонологии Института клинической медицины имени Н.В. Склифосовского ПМГМУ им. И.М. Сеченова МЗ РФ (Сеченовский Университет); ведущий научный  сотрудник НИИ пульмонологии ФМБА.

119991, Москва, ул. Трубецкая, 8, стр. 2; 115682, Москва, Ореховый бульвар, 28

тел.: (495) 708-35-76

SPIN-код: 1645-5524

Sergey N. Avdeev - Doctor  of Medicine,  Professor, Academician  of Russian Academy of Sciences, Head of the Department of Pulmonology, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University of the Ministry of Health  of the Russian Federation (Sechenov University); Leading Researcher,  Federal Pulmonology  Research Institute, Federal Medical and Biological Agency of Russia.

Trubetskaya ul. 8, build. 2, Moscow, 119991; Orekhovyy bul’var 28,  Moscow, 115682

tel.: (495) 708-35-76

SPIN-code: 1645-5524

serg_avdeev@list.ruhttps://orcid.org/0000-0002-4044-674XАйсановЗ. Р.AisanovZ. R.

Айсанов Заурбек Рамазанович – доктор медицинских наук, профессор кафедры пульмонологии.

117997, Москва, ул. Островитянова, 1

тел.: (495) 965-34-66

Zaurbek R. Aisanov - Doctor  of Medicine,  Professor, Department of Pulmonology, Pirogov Russian National  Research  Medical University (Pirogov Medical University),  Healthcare Ministry of Russia.

Ostrovityanova ul. 1, Moscow, 117997

tel.: (495) 965-34-66

aisanov@mail.ruhttps://orcid.org/0000-0001-5032-5442БарановаО. П.BaranovaO. P.

Баранова Ольга Петровна – кандидат медицинских наук, старший  научный  сотрудник  Научно-исследовательского института  интерстициальных и орфанных заболеваний легких.

197022, Санкт-Петербург, ул. Льва Толстого, 6–8

тел.: (812) 499-68-40

Olga P. Baranova - Candidate  of Medicine,  Senior Researcher,  Research Institute of Interstitial  and Orphan  Lung Diseases, Federal  State Budgetary Educational  Institution of Higher Education  “Academician I.P.Pavlov First St. Petersburg State Medical University” of the Ministry of Healthcare of Russian Federation.

L’va Tolstogo ul. 6 – 8, Saint-Petersburg, 197089

tel.: (812) 499-68-40

dr_baranova@mail.ruhttps://orcid.org/0000-0001-7423-5433БорисовС. Е.BorisovS. E.

Борисов Сергей Евгеньевич – доктор медицинских наук, профессор, заместитель директора по научно-клинической работе.

107076, Москва, ул. Стромынка, 10

тел.: (903) 777-06-56

Sergey E. Borisov - Doctor of Medicine, Professor, Deputy Director for Scientific and Clinical Work, State Budgetary Healthcare Institution  of the Moscow City “Moscow City Scientific and Practical Center for Combating Tuberculosis, Moscow City Department of Healthcare.

Stromynka ul. 10, Moscow, 107076

tel.: (903) 777-06-56

sebarsik@gmail.comhttps://orcid.org/0000-0003-0547-3686ГеппеН. А.GeppeN. A.

Геппе Наталия Анатольевна – доктор медицинских наук, профессор, заведующая кафедрой детских болезней института клинической медицины.

119991, Москва,  ул. Трубецкая, 8, стр. 2

тел.: (499) 248-44-22

Natal’ya A. Geppe - Doctor of Medicine, Professor, Head of Department of Pediatric Diseases, Therapeutic Faculty, Federal State Autonomous Educational Institution of Higher Education  I.M. Sechenov First Moscow State Medical University of the Ministry of Health  of the Russian Federation (Sechenov University).

Trubetskaya ul. 8, build. 2, Moscow, 119991

tel.: (499) 248-44-22

geppe@mail.ruhttps://orcid.org/0000-0001-5028-5276ВизельА. А.Vizel’A. A.

Визель Александр Андреевич – доктор медицинских наук, профессор, заведующий кафедрой фтизиопульмонологии.

420012, Республика Татарстан, Казань, ул. Бутлерова, 49

тел.: (987) 296-25-99

SPIN:  5918-5465; Author ID: 195447

Aleksandr A. Vizel’ - Doctor  of Medicine, Professor,  Head  of Department of Phthisiopulmonology and Pulmonology, Kazan’ State Medical University, Healthcare Ministry of Russia.

Butlerova ul. 49, Kazan’, 420012, Tatarstan Republic

tel.: (987) 296-25-99

SPIN:  5918-5465; Author ID: 195447

lordara@inbox.ruhttps://orcid.org/0000-0002-8855-8177ВизельИ. Ю.Vizel’I. Yu.

Визель Ирина Юрьевна – доктор медицинских наук, профессор Российской академии естествознания, доцент кафедры  фтизиопульмонологии.

420012, Республика Татарстан, Казань, ул. Бутлерова, 49

тел.: (917) 903-91-13

Irina Yu. Vizel’ - Doctor  of Medicine,  Professor, Russian Academy of Natural Sciences, Associate Professor, Department of Phthisiopulmonology and Pulmonology, Kazan’ State Medical University, Healthcare  Ministry of Russia.

Butlerova ul. 49, Kazan’, 420012, Tatarstan Republic

tel.: (917) 903-91-13

tatpulmo@mail.ruhttps://orcid.org/0000-0002-0934-7313ЗайцевА. А.ZaicevA. A.

Зайцев Андрей Алексеевич – доктор медицинских наук, профессор, главный пульмонолог.

105094, Москва, Госпитальная пл., 3

тел.: (495) 263-10-47

SPIN-код: 6549-5154, Author ID: 217005

Andrey A. Zaicev - Doctor  of Medicine, Professor,  Chief Pulmonologist, Main Military Clinical Hospital  named  after academician N.N. Burdenko, Ministry of Defense of the Russian Federation.

Gospital’naya pl. 3, Moscow, 105229

SPIN: 6549-5154, Author ID: 217005

a-zaicev@yandex.ruhttps://orcid.org/0000-0001-5228-7793КравченкоН. Ю.KravchenkoN. Y.

Кравченко Наталья Юрьевна – врач-пульмонолог, заведующая организационно-методическим отделом по аллергологии-иммунологии и пульмонологии.

115088, Москва, ул. Шарикоподшипниковская, 9

тел.: (916) 118-32-19

Natalya Y. Kravchenko - Pulmonologist,  Head of the Organizational and Methodological Department for Allergology-Immunology and Pulmonology, State Budgetary Institution “Scientific Research Institute of Health Organization and Medical Management, Moscow City Department of Healthcare”.

Sharikopodshipnikovskaya ul. 9, Moscow, 115088

tel.: (916) 118-32-19

pulmokongress@mail.ruhttps://orcid.org/0000-0001-5191-445XИльковичМ. М.IlkovichM. M.

Илькович Михаил Михайлович – доктор медицинских наук, профессор, заведующий  кафедрой  пульмонологии факультета  последипломного образования, директор  Научно-исследовательского института  интерстициальных и орфанных заболеваний легких.

197022, Санкт-Петербург, ул. Льва Толстого, 6–8

тел.: (812) 338-78-32

SPIN-код: 6239-7007, Author ID: 665454

Mikhail M. Ilkovich - Doctor  of Medicine,  Professor, Head of pulmonology Department of Postgraduate School, Director of Interstitial and Orphan Lung Diseases Research Institute, Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation.

L’va Tolstogo ul. 6 – 8, Saint-Petersburg, 197089

tel.: (812) 338-78-32

SPIN-код: 6239-7007, Author ID: 665454

mih.ilkovich@yandex.ruhttps://orcid.org/0000-0002-3091-4677ЛовачеваО. В.LovachevaO. V.

Ловачева Ольга Викторовна – доктор медицинских наук, профессор, главный научный сотрудник отдела дифференциальной диагностики и лечения туберкулеза и сочетанных  инфекций.

127473, Москва, ул. Достоевского, 4, корп. 2

тел.: (495) 681-84-22

Ol’ga V. Lovacheva - Doctor of Medicine, Professor, Chief Researcher, Department of Differential Diagnosis and Treatment of Tuberculosis and Combined Infections,  Federal State Budgetary Institution “National Medical Research Center for Phthisiopulmonology and Infectious Diseases”, Ministry of Healthcare of Russian Federation.

Dostoyevskogo ul. 4, build. 2, Moscow, 127473

tel.: (495) 681-84-22

olga.lovacheva@yandex.ruhttps://orcid.org/0000-0002-2686-8284МалаховА. Б.MalakhovA. B.

Малахов Александр Борисович – доктор медицинских наук, профессор кафедры  детских болезней.

119991, Москва, ул. Трубецкая, 8, стр. 2

тел.: (985) 970-73-11

Aleksandr B. Malakhov - Doctor of Medicine,  Professor, Department of Pediatric Diseases, I.M. Sechenov First Moscow State Medical University of the Ministry of Health  of the Russian Federation (Sechenov  University).

Trubetskaya ul. 8, build. 2, Moscow, 119991,

tel.: (985) 970-73-11

alexis4591m@mail.ruhttps://orcid.org/0000-0002-6128-5914МалявинA. Г.MalyavinA. G.

Малявин Андрей Георгиевич – доктор медицинских наук, профессор кафедры фтизиатрии и пульмонологии.

127473, Москва, ул. Делегатская, 20, стр. 1

тел.: (916) 547-83-73

Andrey G. Malyavin - Doctor of Medicine,  Professor, Department of Phthisiology and Pulmonology,  Federal State Budgetary Educational  Institution of the Higher Education “ A.I. Yevdokimov Moscow State University of Medicine and Dentistry”  of the Ministry of Healthcare  of the Russian Federation.

Delegatskaya ul. 20/1, Moscow, 127473

tel.: (916) 547-83-73

maliavin@mail.ruhttps://orcid.org/0000-0002-5815-5895ПетровД. В.PetrovD. V.

Петров Дмитрий Владимирович – ассистент кафедры пропедевтики внутренних  болезней.

644043, Омск, ул. Ленина, 12

тел.: (913) 968-69-47

Dmitriy V. Petrov - Assistant Lecturer, Department of Propaedeutics of Internal Diseases, Omsk State Medical University, Healthcare  Ministry of Russia.

Lenina ul. 12, Omsk, 644099

tel.: (913) 968-69-47

dmitrpetrov@bk.ruhttps://orcid.org/0000-0002-0690-3345РомановВ. В.RomanovV. V.

Романов Владимир Викторович – доктор медицинских наук, профессор, заведующий отделом фтизиатрии.

107564, Москва, Яузская аллея, 2

тел.: (916) 169-84-60

Vladimir V. Romanov - Doctor of Medicine, Professor, Head of the Department of Phthisiology, Federal State Scientific Institution “Central Research Institute of Tuberculosis”.

Yauzskaya alleya 2, Moscow, 107564

tel.: (916) 169-84-60

romanov-vladimir-vik@yandex.ruhttps://orcid.org/0000-0002-8170-3300СивокозовИ. В.SivokozovI. V.

Сивокозов Илья Владимирович – кандидат медицинских наук, заведующий  отделением  эндоскопии Центра  диагностики и реабилитации заболеваний органов дыхания.

107564, Москва, Яузская аллея, 2

тел.: (915) 132-27-89

Ilya V. Sivokozov - Candidate of Medicine, Head of Department of endoscopy, Center  for Diagnosis and Rehabilitation of Respiratory  Diseases, Federal State Scientific Institution “Central  Research Institute of Tuberculosis”.

Yauzskaya alleya 2, Moscow, 107564

tel.: (915) 132-27-89

grand63@yandex.ruhttps://orcid.org/0000-0001-8170-1260СамсоноваМ. В.SamsonovaM. V.

Самсонова Мария Викторовна – доктор медицинских наук, заведующая лабораторией патологической  анатомии  и иммунологии НИИ пульмонологии ФМБА России; старший  научный  сотрудник  лаборатории инновационной патоморфологии МКНЦ им. А.С. Логинова ДЗ г. Москвы.

115682, Москва,  Ореховый бульвар, 28; 111123, Москва, шоссе Энтузиастов, 86

тел.: (495) 465-58-59

Mariya V. Samsonova - Doctor of Medicine, Head of Laboratory of Pathological Anatomy and Immunology,  Federal Pulmonology Research Institute,  Federal Medical and Biological Agency of Russia, Senior Researcher,  Laboratory of Innovative  Pathomorphology, State Budgetary Institution Moscow Clinical Scientific Center named after Loginov, Moscow City Department of Healthcare.

Orekhovyy bul’var 28, Moscow, 115682; Shosse Entuziastov 86, Moscow, 111123

tel.: (495) 465-58-59

samary@mail.ruhttps://orcid.org/0000-0002-0757-6796СоловьеваИ. П.SolovievaI. P.

Соловьева Ирина Павловна – доктор медицинских наук, профессор, заведующая  лабораторией  патологической анатомии.

119991, Москва, ул. Трубецкая, 8, стр. 2

тел.: (499) 268-25-26

Irina P. Solovieva - Doctor of Medicine,  Professor, Head of the Laboratory of Pathological  Anatomy,  Federal  State Autonomous  Educational Institution of Higher Education  I.M. Sechenov First Moscow State Medical University of the Ministry of Health  of the Russian Federation (Sechenov  University).

Trubetskaya ul. 8, build. 2, Moscow, 119991,

tel.: (499) 268-25-26

cheral12@gmail.comhttps://orcid.org/0000-0002-2985-3379СтепанянИ. Э.StepanyanI. E.

Степанян Игорь Эмильевич – доктор медицинских наук, профессор, ведущий  научный сотрудник  отдела дифференциальной диагностики туберкулеза и экстракорпоральных методов лечения,  советник  директора.

107564, Москва, Яузская аллея, 2

тел.: (499) 169-99-51

SPIN-code: 8854-5951; Author ID: 443264

Igor’ E. Stepanyan - Doctor of Medicine, Professor, Leading Researcher, Division of Differential Diagnosis of Pulmonary Tuberculosis and Extracorporeal Therapeutic Methods, Federal Central Research Institute of Tuberculosis.

Yauzskaya alleya 2, Moscow, 107564

tel.: (499) 169-99-51

SPIN-code: 8854-5951; Author ID: 443264

drstepanyan@mail.ruhttps://orcid.org/0000-0001-5444-5943ТерпигоревС. А.TerpigorevS. A.

Терпигорев Станислав Анатольевич – доктор медицинских наук, профессор, руководитель отделения профессиональной патологии и врачебно-трудовой экспертизы.

129110, Москва, ул. Щепкина, 61 / 2

тел.: (495) 681-03-71

SPIN-code: 9404-3122

Stanislav A. Terpigorev - Doctor of Medicine,  Professor, Head of Department of Occupational Diseases and Medical  Expertise,  M.F. Vladimirskiy  State Moscow Regional Research Clinical Institute.

Shchepkina ul. 61/2, Moscow, 129110

tel.: (495) 681-03-71

smith42@yandex.ruhttps://orcid.org/0000-0003-3931-1431ТюринИ. Е.TyurinI. E.

Тюрин Игорь Евгеньевич – д. м. н., профессор, заведующий кафедрой рентгенологии и радиологии.

123995, Москва, ул. Баррикадная, 2, стр. 1

тел.: (903) 758-46-52

SPINcode: 6499-2398

Igor’ E. Tyurin, Doctor of Medicine, Professor, Head of Department of Radiology

ul. Barrikadnaya 2/1, Moscow, 123995

tel.: (903) 758-46-52

SPIN-code: 6499-2398

igortyurin@gmail.comhttps://orcid.org/0000-0003-1604-3446ФранцузевичЛ. Я.FrantsuzevichL. Ya.

Французевич Лайне Яновна – ассистент кафедры пульмонологии факультета дополнительного профессионального образования Федерального образования «Российский национальный исследовательский медицинский университет имени Н.И.Пирогова» Министерства здравоохранения Российской Федерации, стажер-исследователь отдела внутренних болезней Медицинского научно-образовательного центра Федерального государственного бюджетного образовательного учреждения высшего образования «Московский государственный университет имени М.В.Ломоносова».

117997, Москва, ул. Островитянова, 1119991, Москва, Ленинские горы, 1

тел.: (499) 248-57-55

Layne Ya. Frantsuzevich, Assistant Lecturer, Department of Pulmonology, Pirogov Russian National Research Medical University (Pirogov Medical University), Ministry of Health of the Russian Federation, Intern Researcher, Department of Internal Medicine, Medical Research and Education Center, Federal State Budget Educational Institution of Higher Education M.V.Lomonosov Moscow State University.

Leninskie gory 1, Moscow, 119991ul. Ostrovityanova 1, Moscow, 117997

tel.: (499) 248-57-55

frantsuzevitch@mail.ruhttps://orcid.org/0000-0002-0158-7056ЧерняевА. Л.ChernyaevA. L.

Черняев Андрей Львович – доктор медицинских наук,  профессор, профессор кафедры патологической анатомии и клинической патологической анатомии лечебного  факультета  РНИМУ им. Н.И. Пирогова МЗ РФ; заведующий отделом фундаментальной пульмонологии НИИ пульмонологии ФМБА России; ведущий научный  сотрудник  лаборатории клинической морфологии НИИ морфологии человека им. ак. А.П. Авцына РНЦ хирургии им. ак. Б.В. Петровского.

117997, Москва, ул. Островитянова, 1; 115682, Москва,  Ореховый бульвар, 28; 117418, Москва, ул. Цюрупы, 3

тел.: (495) 465-58-59

Andrey L. Chernyaev - Doctor of Medicine, Professor, Professor of the Department of Pathological Anatomy and Clinical Pathological Anatomy, Faculty of Medicine,  Pirogov Russian National  Research Medical University (Pirogov Medical University), Healthcare Ministry of Russia; Head of the Department of Fundamental Pulmonology, Federal Pulmonology Research Institute, Federal Medical and Biological Agency of Russia; Leading Researcher, Laboratory of Clinical Morphology, Avtsyn Research Institute оf Human Morphology оf Petrovsky National Research Centre оf Surgery.

Ostrovityanova ul. 1, Moscow, 117997; Orekhovyy bul’var 28,  Moscow, 115682; Tsyurupy ul. 3, Moscow, 117418

tel.: (495) 465-58-59

cheral12@gmail.comhttps://orcid.org/0000-0002-1908-5601ШмелевЕ. И.ShmelevE. I.

Шмелев Евгений Иванович – доктор медицинских наук, профессор, заведующий отделом дифференциальной диагностики туберкулеза  легких и экстракорпоральных методов лечения.

107564, Москва, Яузская аллея, 2

тел.: (499) 785-90-08

Evgeniy I. Shmelev - Doctor of Medicine,  Professor, Head of Differential Diagnosis of Pulmonary Tuberculosis and Extracorporeal Methods of Treatment Department, Federal State Scientific Institution “Central  Research Institute of Tuberculosis”.

Yauzskaya alleya 2, Moscow, 107564

tel.: (499) 785-90-08 

eishmelev@mail.ruШмелеваН. М.ShmelevaN. M.

Шмелева Наталья Михайловна – кандидат медицинских наук, старший научный сотрудник отдела дифференциальной диагностики туберкулеза и экстракорпоральных методов лечения.

107564, Москва, Яузская аллея, 2

тел.: (499) 785-90-31

Natalia M. Shmeleva - Сandidate of Medicine, Senior Researcher, Differential Diagnosis of pulmonary  Tuberculosis  and Extracorporal Treatment Department, Federal State Scientific Institution “Central  Research Institute of Tuberculosis”.

Yauzskaya alleya 2, Moscow, 107564

tel.: (499) 785-90-31

eishmelev@mail.ruРоссийский национальный исследовательский медицинский университет имени Н.И. Пирогова Министерства здравоохранения Российской ФедерацииРоссияPirogov Russian National Research Medical University (Pirogov Medical University), Healthcare Ministry of RussiaRussian FederationПервый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет); Научно-исследовательский институт пульмонологии Федерального медико-биологического агентства РоссииРоссияI.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University); Federal Pulmonology Research Institute, Federal Medical and Biological Agency of RussiaRussian FederationПервый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова Министерства здравоохранения Российской ФедерацииРоссияAcademician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian FederationRussian FederationМосковский городской научно-практический центр борьбы с туберкулезом Департамента здравоохранения города МосквыРоссияMoscow City Scientific and Practical Center for Combating Tuberculosis, Moscow City Department of HealthcareRussian FederationПервый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет):РоссияI.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)Russian FederationКазанский государственный медицинский университет Министерства здравоохранения Российской ФедерацииРоссияKazan’ State Medical University, Healthcare Ministry of RussiaRussian FederationГлавный военный клинический госпиталь имени академика Н.Н. Бурденко Министерства обороны Российской ФедерацииРоссияMain Military Clinical Hospital named after academician N.N. Burdenko, Ministry of Defense of the Russian FederationRussian FederationНаучно-исследовательский институт организации здравоохранения и медицинского менеджмента Департамента здравоохранения города МосквыРоссияScientific Research Institute of Health Organization and Medical Management of the Moscow City Department of HealthcareRussian FederationНациональный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний Министерства здравоохранения Российской ФедерацииРоссияNational Medical Research Center for Phthisiopulmonology and Infectious Diseases, Ministry of Healthcare of Russian FederationRussian FederationПервый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет)РоссияI.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)Russian FederationМосковский государственный медико-стоматологический университет имени А.И. Евдокимова Министерства здравоохранения Российской ФедерацииРоссияA.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of the Russian FederationRussian FederationОмский государственный медицинский университет Министерства здравоохранения Российской ФедерацииРоссияOmsk State Medical University, Healthcare Ministry of RussiaRussian FederationЦентральный научно-исследовательский институт туберкулезаРоссияCentral Research Institute of TuberculosisRussian FederationНаучно-исследовательский институт пульмонологии Федерального медико-биологического агентства России; Московский клинический научно-практический центр имени А.С. Логинова Департамента здравоохранения города МосквыРоссияFederal Pulmonology Research Institute, Federal Medical and Biological Agency of Russia; State Budgetary Institution Moscow Clinical Scientific Center named after Loginov, Moscow City Department of HealthcareRussian FederationПервый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет)РоссияI.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)Russian FederationМосковский областной научно-исследовательский клинический институт имени М.Ф. ВладимирскогоРоссияM.F. Vladimirskiy State Moscow Regional Research Clinical InstituteRussian FederationФедеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования «Российская медицинская академия непрерывного профессионального образования» Министерства здравоохранения Российской ФедерацииРоссияRussian Federal Academy of Continued Medical Education, Healthcare Ministry of RussiaRussian FederationФедеральное государственное автономное образовательное учреждение высшего образования «Российский национальный исследовательский медицинский университет имени Н.И.Пирогова» Министерства здравоохранения Российской Федерации; Федеральное государственное бюджетное образовательное учреждение высшего образования «Московский государственный университет имени М.В.Ломоносова»РоссияPirogov Russian National Research Medical University (Pirogov Medical University), Healthcare Ministry of Russia; Federal State Budget Educational Institution of Higher Education M.V.Lomonosov Moscow State UniversityRussian FederationРоссийский национальный исследовательский медицинский университет имени Н.И. Пирогова Министерства здравоохранения Российской Федерации; Научно-исследовательский институт пульмонологии Федерального медико-биологического агентства России; Научно-исследовательский институт морфологии человека имени академика А.П. Авцына Российского научного центра хирургии имени академика Б.В. ПетровскогоРоссияPirogov Russian National Research Medical University (Pirogov Medical University), Healthcare Ministry of Russia; Federal Pulmonology Research Institute, Federal Medical and Biological Agency of Russia; Avtsyn Research Institute of Human Morphology of Federal State Budgetary Scientific Institution “Petrovsky National Research Centre of Surgery”Russian Federation202211122022326806833Copyright © Чучалин А.Г., Авдеев С.Н., Айсанов З.Р., Баранова О.П., Борисов С.Е., Геппе Н.А., Визель А.А., Визель И.Ю., Зайцев А.А., Кравченко Н.Ю., Илькович М.М., Ловачева О.В., Малахов А.Б., Малявин A.Г., Петров Д.В., Романов В.В., Сивокозов И.В., Самсонова М.В., Соловьева И.П., Степанян И.Э., Терпигорев С.А., Тюрин И.Е., Французевич Л.Я., Черняев А.Л., Шмелев Е.И., Шмелева Н.М., 20222022Чучалин А.Г., Авдеев С.Н., Айсанов З.Р., Баранова О.П., Борисов С.Е., Геппе Н.А., Визель А.А., Визель И.Ю., Зайцев А.А., Кравченко Н.Ю., Илькович М.М., Ловачева О.В., Малахов А.Б., Малявин A.Г., Петров Д.В., Романов В.В., Сивокозов И.В., Самсонова М.В., Соловьева И.П., Степанян И.Э., Терпигорев С.А., Тюрин И.Е., Французевич Л.Я., Черняев А.Л., Шмелев Е.И., Шмелева Н.М.Chuchalin A.G., Avdeev S.N., Aisanov Z.R., Baranova O.P., Borisov S.E., Geppe N.A., Vizel’ A.A., Vizel’ I.Y., Zaicev A.A., Kravchenko N.Y., Ilkovich M.M., Lovacheva O.V., Malakhov A.B., Malyavin A.G., Petrov D.V., Romanov V.V., Sivokozov I.V., Samsonova M.V., Solovieva I.P., Stepanyan I.E., Terpigorev S.A., Tyurin I.E., Frantsuzevich L.Y., Chernyaev A.L., Shmelev E.I., Shmeleva N.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/4155

Саркоидоз является полиорганным гранулематозом неизвестной природы. При помощи  современных методов диагностики это заболевание возможно выявить на ранних стадиях. Для установления диагноза на основании сопоставления лучевых, клинических, морфологических и функциональных данных при отсутствии специфических маркеров требуется комплексный поход. Варианты течения саркоидоза без поражения органов дыхания представляют  значительные трудности. Во избежание  раннего  назначения гормонов  и цитостатических препаратов и, наоборот, в целях своевременного реагирования на прогрессирование и угрожающие состояния крайне актуально понимание времени  и средств  начала  лечения  саркоидоза.  Методы. Клинические рекомендации созданы  на основании анализа данных последних исследований саркоидоза, опубликованных на русском и английском языках. Каждый  тезис-рекомендация по проведению диагностических и лечебных мероприятий оценивается по шкалам оценки  уровня достоверности доказательств (1–5)  и убедительности  рекомендаций (по категориям  А, В, С). Клинические рекомендации содержат также комментарии и разъяснения к указанным тезисам-рекомендациям, алгоритмы  по диагностике, тактике терапии,  справочные материалы по использованию рекомендуемых препаратов. Целевой  аудиторией  данных  клинических рекомендаций являются  терапевты,  врачи  общей  практики,  пульмонологи, фтизиатры,  ревматологи,  дерматологи,   специалисты  лучевой  диагностики,  иммунологи, клинические  фармакологи.  Заключение. По данным представленных клинических рекомендаций освещаются современные сведения об эпидемиологии, клинических проявлениях,  диагностике и тактике  ведения  пациентов с саркоидозом. Одобрены  решением Научно-практического совета  Министерства здравоохранения Российской Федерации (2022).

Sarcoidosis is a multi-organ granulomatosis  of unknown  origin. Modern  diagnostic methods  allow detecting  this disease at an early stage. The absence of specific markers requires a comprehensive  approach  to diagnosis based on comparison  of radiation,  clinical, morphological  and functional data. The course of sarcoidosis without damage to the respiratory system presents significant difficulties. It is extremely important  to understand the time and means of starting Sarcoidosis’s treatment to avoid the early initiation  of hormones  and cytostatics and, on the other hand,  to timely respond to progression and threatening  conditions.  Methods. Clinical recommendations are based on the analysis of Russian and English publications of the latest sarcoidosis research. The target audience of these clinical guidelines are therapists, general practitioners, pulmonologists, TB doctors, rheumatologists,  dermatologists,  radiation diagnosticians,  immunologists,  and clinical pharmacologists.  Each thesis-recommendation for diagnosis and treatment is evaluated on an 1 to 5 scale of levels of evidence and an A, B, C scale of the grades of recommendations. The clinical guidelines also contain comments and explanations for the theses-recommendations, diagnostic algorithms, treatment strategies, reference materials on the use of recommended drugs. Conclusion. Current information  on epidemiology, clinical manifestations,  diagnosis and management  strategies for patients with sarcoidosis are covered in the presented clinical guidelines. Approved by the decision of the Scientific and Practical Council of the Ministry of Health of the Russian Federation (2022).

саркоидоздиагностикаклинические проявлениялечениеsarcoidosisdiagnosisclinical manifestationstreatmentReferencesВизель А.А., ред. Саркоидоз. М.: Атмосфера; 2010.Vizel’ A.A, ed. [Sarcoidosis]. Moscow: Atmosphera; 2010 (in Russian).ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis statement committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur. Respir. J. 1999; 14 (4): 735–737. DOI: 10.1034/j.1399-3003.1999.14d02.x.ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis statement committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur. Respir. J. 1999; 14 (4): 735–737. DOI: 10.1034/j.1399-3003.1999.14d02.x.Landi C., Carleo A., Cillis G., Rottoli P. Sarcoidosis: proteomics and new perspectives for improving personalized medicine. Expert Rev. Proteomics. 2018; 15 (10): 829–835. DOI: 10.1080/14789450.2018.1528148.Landi C., Carleo A., Cillis G., Rottoli P. Sarcoidosis: proteomics and new perspectives for improving personalized medicine. Expert Rev. Proteomics. 2018; 15 (10): 829–835. DOI: 10.1080/14789450.2018.1528148.Besnard V., Calender A., Bouvry D. et al. G908R NOD2 variant in a family with sarcoidosis. Respir. Res. 2018; 19 (1): 44. DOI: 10.1186/s12931-018-0748-5.Besnard V., Calender A., Bouvry D. et al. G908R NOD2 variant in a family with sarcoidosis. Respir. Res. 2018; 19 (1): 44. DOI: 10.1186/s12931-018-0748-5.Хоменко А.Г., Швайгер О., ред. Саркоидоз. М.: Медицина; 1982.Khomenko A.G., Shvayger O., eds. [Sarcoidosis]. Moscow: Meditsina; 1982 (in Russian).Zhao M.M., Du S.S., Li Q.H. et al. High throughput 16SrRNA gene sequencing reveals the correlation between Propionibacterium acnes and sarcoidosis. Respir. Res. 2017; 18 (1): 28. DOI: 10.1186/s12931-017-0515-z.Zhao M.M., Du S.S., Li Q.H. et al. High throughput 16SrRNA gene sequencing reveals the correlation between Propionibacterium acnes and sarcoidosis. Respir. Res. 2017; 18 (1): 28. DOI: 10.1186/s12931-017-0515-z.van Dee L., Stehouwer M., van Bemmel T. Systemic sarcoidosis associated with exposure to Borrelia burgdorferi in a 21-year-old man. Eur. J. Case Rep. Intern. Med. 2018; 5 (10): 000942. DOI: 10.12890/2018_000942.van Dee L., Stehouwer M., van Bemmel T. Systemic sarcoidosis associated with exposure to Borrelia burgdorferi in a 21-year-old man. Eur. J. Case Rep. Intern. Med. 2018; 5 (10): 000942. DOI: 10.12890/2018_000942.Esteves T., Aparicio G., Garcia-Patos V. Is there any association between sarcoidosis and infectious agents? a systematic review and meta-analysis. BMC Pulm. Med. 2016; 16 (1): 165. DOI: 10.1186/s12890-016-0332.Esteves T., Aparicio G., Garcia-Patos V. Is there any association between sarcoidosis and infectious agents? a systematic review and meta-analysis. BMC Pulm. Med. 2016; 16 (1): 165. DOI: 10.1186/s12890-016-0332.García Ródenas M.D.M., Gayá García-Manso I., García Sevila R. Sarcoidosis associated with Interferon beta treatment. Med. Clin. (Barc). 2019; 153 (5): e21–22. DOI: 10.1016/j.medcli.2018.11.021.García Ródenas M.D.M., Gayá García-Manso I., García Sevila R. Sarcoidosis associated with Interferon beta treatment. Med. Clin. (Barc). 2019; 153 (5): e21–22. DOI: 10.1016/j.medcli.2018.11.021.Визель А.А., Визель И.Ю. Саркоидоз и интерфероны: звенья патогенеза и ятрогения. Практическая пульмонология. 2017; (1): 46–50. Доступно на: https://atmosphere-ph.ru/modules/Magazines/articles/pulmo/pp_1_2017_46.pdfVizel’ A.A., Vizel’ I.Yu. [Sarcoidosis and interferons: pathogenesis and iatrogeny]. Prakticheskaya pul’monologiya. 2017; (1): 46–50. Available at: https://atmosphere-ph.ru/modules/Magazines/articles/pulmo/pp_1_2017_46.pdf (in Russian).Bargagli E., Prasse A. Sarcoidosis: a review for the internist. Intern. Emerg. Med. 2018; 13 (3): 325–331. DOI: 10.1007/s11739-017-1778-6.Bargagli E., Prasse A. Sarcoidosis: a review for the internist. Intern. Emerg. Med. 2018; 13 (3): 325–331. DOI: 10.1007/s11739-017-1778-6.Baughman R.P., Culver D.A., Judson M.A. A concise review of pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 2011; 183 (5): 573–581. DOI: 10.1164/rccm.201006-0865ci.Baughman R.P., Culver D.A., Judson M.A. A concise review of pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 2011; 183 (5): 573–581. DOI: 10.1164/rccm.201006-0865ci.Patterson K.C., Chen E.S. The pathogenesis of pulmonary sarcoidosis and implications for treatment. Chest. 2018; 153 (6): 1432–1442. DOI: 10.1016/j.chest.2017.11.030.Patterson K.C., Chen E.S. The pathogenesis of pulmonary sarcoidosis and implications for treatment. Chest. 2018; 153 (6): 1432–1442. DOI: 10.1016/j.chest.2017.11.030.Hu Y., Yibrehu B., Zabini D., Kuebler W.M. Animal models of sarcoidosis. Cell Tissue Res. 2017; 367 (3): 651–661. DOI: 10.1007/s00441-016-2526-3.Hu Y., Yibrehu B., Zabini D., Kuebler W.M. Animal models of sarcoidosis. Cell Tissue Res. 2017; 367 (3): 651–661. DOI: 10.1007/s00441-016-2526-3.Dubaniewicz A. [“Danger theory”as a common mechanism of sarcoidosis induction by infectious and non-infectious factors – a role of environmental factors and autoimmunity]. Pol. Merkur. Lekarski. 2018; 44 (261): 97–100. Available at: https://www.researchgate.net/publication/324130127_Danger_theory_as_a_common_mechanism_of_sarcoidosis_induction_by_infectious_and_non-infectious_factors_-_a_role_of_genetics_factorsDubaniewicz A. [“Danger theory”as a common mechanism of sarcoidosis induction by infectious and non-infectious factors – a role of environmental factors and autoimmunity]. Pol. Merkur. Lekarski. 2018; 44 (261): 97–100. Available at: https://www.researchgate.net/publication/324130127_Danger_theory_as_a_common_mechanism_of_sarcoidosis_induction_by_infectious_and_non-infectious_factors_-_a_role_of_genetics_factorsJouni H., Chareonthaitawee P. Unraveling inflammation and oxidative stress in cardiac sarcoidosis. Circ. Cardiovasc. Imaging. 2017; 10 (12): e007287. DOI: 10.1161/CIRCIMAGING.117.007287.Jouni H., Chareonthaitawee P. Unraveling inflammation and oxidative stress in cardiac sarcoidosis. Circ. Cardiovasc. Imaging. 2017; 10 (12): e007287. DOI: 10.1161/CIRCIMAGING.117.007287.Ruža I., Lucāne Z. Serum and urinary calcium level in Latvian patients with sarcoidosis. Reumatologia. 2018; 56 (6): 377–381. DOI: 10.5114/reum.2018.80715.Ruža I., Lucāne Z. Serum and urinary calcium level in Latvian patients with sarcoidosis. Reumatologia. 2018; 56 (6): 377–381. DOI: 10.5114/reum.2018.80715.Suzuki T., Tsushima K., Kawata N. et al. Estimation using the impulse oscillation system in patients with pulmonary sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2015; 32 (2): 144–150. Available at: https://www.researchgate.net/publication/280876634_Estimation_Using_The_Impulse_Oscillation_System_In_Patients_With_Pulmonary_SarcoidosisSuzuki T., Tsushima K., Kawata N. et al. Estimation using the impulse oscillation system in patients with pulmonary sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2015; 32 (2): 144–150. Available at: https://www.researchgate.net/publication/280876634_Estimation_Using_The_Impulse_Oscillation_System_In_Patients_With_Pulmonary_SarcoidosisЕвфимьевский В.П., Борисов С.Е., Богородская Е.М. Нарушения дыхательной функции при гранулематозах и распространенных поражениях иной природы: пособие для врачей. М.; 1998.Evfim’evskiy V.P., Borisov S.E., Bogorodskaya E.M. [Respiratory disorders in granulomatosis and common lesions of a different nature: a guide for physicians]. Moscow; 1998 (in Russian).Van Schalkwyk E.M., Bezuidenhout J., Wyser C.P. et al. Comparison of bronchoalveolar lavage, open lung biopsy and lung function in sarcoidosis. Eur. Resp. J. 1997; 10 (Suppl. 25): 206s. Available at: https://eurekamag.com/research/030/633/030633831.phpVan Schalkwyk E.M., Bezuidenhout J., Wyser C.P. et al. Comparison of bronchoalveolar lavage, open lung biopsy and lung function in sarcoidosis. Eur. Resp. J. 1997; 10 (Suppl. 25): 206s. Available at: https://eurekamag.com/research/030/633/030633831.phpUngprasert P., Matteson E.L. Neurosarcoidosis. Rheum. Dis. Clin. North Am. 2017; 43 (4): 593–606. DOI: 10.1016/j.rdc.2017.06.008.Ungprasert P., Matteson E.L. Neurosarcoidosis. Rheum. Dis. Clin. North Am. 2017; 43 (4): 593–606. DOI: 10.1016/j.rdc.2017.06.008.Duong H., Bonham C.A. Sarcoidosis-associated pulmonary hypertension: pathophysiology, diagnosis, and treatment. Clin. Pulm. Med. 2018; 25 (2): 52–60. DOI: 10.1097/CPM.0000000000000252.Duong H., Bonham C.A. Sarcoidosis-associated pulmonary hypertension: pathophysiology, diagnosis, and treatment. Clin. Pulm. Med. 2018; 25 (2): 52–60. DOI: 10.1097/CPM.0000000000000252.Русаков Н.В., Мухин Н.А, Брико Н.И. и др. Особенности распространения саркоидоза в условиях Москвы. Гигиена и санитария. 2012; (4): 16–18. Доступно на: https://cyberleninka.ru/article/n/osobennosti-rasprostraneniya-sarkoidoza-v-usloviyah-moskvy?ysclid=l-93wqbcyxo307456749Rusakov N.V., Mukhin N.A., Briko N.I. et al. Features of prevalence of sarcoidosis among the inhabitants of Moscow]. Gigiena i sanitariya. 2012; (4): 16–18. Available at: https://cyberleninka.ru/article/n/osobennosti-rasprostraneniya-sarkoidoza-v-usloviyah-moskvy?ysclid=l93wqbcyxo307456749 (in Russian).Баранова О.П., Рефицкая Н.В., Степаненко Т.А. и др. Эпидемиология саркоидоза органов дыхания в Санкт-Петербурге (1998–2008). В кн.: Чучалин А.Г., ред. XIX Национальный Конгресс по болезням органов дыхания: cборник трудов. М.: ДизайнПресс; 2009: 216–217.Baranova O.P., Refitskaya N.V., Stepanenko T.A. et al. [Epidemiology of respiratory sarcoidosis in St. Petersburg (1998–2008)]. In: Chuchalin A.G., ed. [XIX National congress on respiratory diseases: collection of works]. Moscow: DesignPress; 2009: 216–217 (in Russian).Петров Д.В., Овсянников Н.В., Коненко А.Ю., и др. Результаты внедрения «Порядка оказания медицинской помощи больным саркоидозом» в городе Омске. Вестник современной клинической медицины. 2013; 6 (2): 42–46. Доступно на: https://cyberleninka.ru/article/n/rezultaty-vnedreniya-poryadka-okazaniya-meditsinskoy-pomoschi-bolnym-sarkoidozom-v-gorode-omske/viewerPetrov D.V., Ovsyannikov N.V., Konenko A.Yu. et al. [Result of the introduction of “Order of medical care of sarcoidosis patients” in Omsk city]. Bulletin of modern clinical medicine. 2013; 6 (2): 42–46. Available at: https://cyberleninka.ru/article/n/rezultaty-vnedreniya-poryadka-okazaniya-meditsinskoy-pomoschi-bolnym-sarkoidozom-v-gorode-omske/viewer (in Russian).Визель И.Ю., Визель А.А. Характеристика регистра больных саркоидозом в Республике Татарстан. Вестник современной клинической медицины. 2015; 8 (5): 18–26. Доступно на: http://vskmjournal.org/images/Files/Issues_Archive/2015/Issue_5/VSKM_2015_N_5_p18-26.pdfVizel’ I.Ju., Vizel’ A.A [Characteristic of sarcoidosis register in the republic of Tatarstan]. Vestnik sovremennoy klinicheskoy mediciny. 2015; 8 (5): 18–26. Available at: http://vskmjournal.org/images/Files/Issues_Archive/2015/Issue_5/VSKM_2015_N_5_p18-26.pdf (in Russian).Крюков Е.В., Антипушина Д.Н., Зайцев А.А. Саркоидоз – актуальная проблема различных силовых ведомств. Вестник Российской военно-медицинской академии. 2016; 56 (4): 224–227.Kryukov E.V., Antipushina D.N., Zaitsev A.A. [Sarcoidosis is an actual problem of various law enforcement agencies]. Vestnik Rossiyskoy voenno-medicinskoy akademii. 2016; 56 (4): 224–227 (in Russian).Baughman R.P., Field S., Costabel U. et al. Sarcoidosis in America. Analysis based on health care use. Ann. Am. Thorac. Soc. 2016; 13 (8): 1244–1252. DOI: 10.1513/annalsats.201511-760oc.Baughman R.P., Field S., Costabel U. et al. Sarcoidosis in America. Analysis based on health care use. Ann. Am. Thorac. Soc. 2016; 13 (8): 1244–1252. DOI: 10.1513/annalsats.201511-760oc.Thomeer M., Demedts M., Vandeurzen K. et al. Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders. Acta Clin. Belg. 2001; 56 (3): 163–172. DOI: 10.1179/acb.2001.026.Thomeer M., Demedts M., Vandeurzen K. et al. Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders. Acta Clin. Belg. 2001; 56 (3): 163–172. DOI: 10.1179/acb.2001.026.Morimoto T., Azuma A., Abe S. et al. Epidemiology of sarcoidosis in Japan. Eur. Respir. J. 2008; 31 (2): 372–379. DOI: 10.1183/09031936.00075307.Morimoto T., Azuma A., Abe S. et al. Epidemiology of sarcoidosis in Japan. Eur. Respir. J. 2008; 31 (2): 372–379. DOI: 10.1183/09031936.00075307.Hoffman A.L., Milman N., Byg K.E. Childhood sarcoidosis in Denmark 1979–1994: incidence, clinical features and laboratory results at presentation in 48 children. Acta Paediatr. 2004; 93 (1): 30–36. DOI: 10.1111/j.1651-2227.2004.tb00670.x.Hoffman A.L., Milman N., Byg K.E. Childhood sarcoidosis in Denmark 1979–1994: incidence, clinical features and laboratory results at presentation in 48 children. Acta Paediatr. 2004; 93 (1): 30–36. DOI: 10.1111/j.1651-2227.2004.tb00670.x.Terwiel M., van Moorsel C.H.M. Clinical epidemiology of familial sarcoidosis: a systematic literature review. Respir. Med. 2019; 149: 36–41. DOI: 10.1016/j.rmed.2018.11.022.Terwiel M., van Moorsel C.H.M. Clinical epidemiology of familial sarcoidosis: a systematic literature review. Respir. Med. 2019; 149: 36–41. DOI: 10.1016/j.rmed.2018.11.022.Визель И.Ю., Шмелев Е.И., Визель А.А., Ганибаева Г.С. Сравнение вновь выявленных больных саркоидозом молодого и старшего возраста. Русский медицинский журнал. 2018; 10 (1): 16–20. Доступно на: https://www.rusmedreview.com/articles/bolezni_dykhatelnykh_putey/Sravnenie_vnovy_vyyavlennyh_bolynyh_sarkoidozom_molodogo_istarshego_vozrasta/Vizel’ I.Yu., Shmelev E.I., Vizel’ A.A., Ganibaeva G.S. [Comparison of newly diagnosed patients with sarcoidosis of young and older age]. Russkiy meditsinskiy zhurnal. 2018; 10 (1):16–20. Available at: https://www.rusmedreview.com/articles/bolezni_dykhatelnykh_putey/Sravnenie_vnovy_vyyavlennyh_bolynyh_sarkoidozom_molodogo_istarshego_vozrasta/ (in Russian).Терпигорев С.А., Эль Зейн Б.А., Верещагина В.М., Палеев Н.Р. Саркоидоз и проблемы его классификации. Вестник РАМН. 2012; (5): 30–37. Доступно на: https://cyberleninka.ru/article/n/sarkoidoz-i-problemy-ego-klassifikatsii/viewerTerpigorev S.A., El Zein B.A., Vereshchagina V.M., Paleev N.R. [Sarcoidosis and problems of its classification]. Vestnik RAMN. 2012; (5): 30–37. Available at: https://cyberleninka.ru/article/n/sarkoidoz-i-problemy-ego-klassifikatsii/viewer (in Russian).Bahmer T., Watz H., Develaska M. et al. Physical activity and fatigue in patients with sarcoidosis. Respiration. 2018; 95 (1): 18–26. DOI: 10.1159/000481827.Bahmer T., Watz H., Develaska M. et al. Physical activity and fatigue in patients with sarcoidosis. Respiration. 2018; 95 (1): 18–26. DOI: 10.1159/000481827.Илькович М.М., Баранова О.П. Саркоидоз органов дыхания. В кн.: Илькович М.М., ред. Интерстициальные и орфанные заболевания легких. М.: ГЭОТАР-Медиа; 2019: 163–234.Il’kovich M.M., Baranova O.P. [Sarcoidosis of the respiratory system]. In: Il’kovich M.M., ed. [Interstitial and orphan lung diseases]. Moscow: GEOTAR-Media; 2019: 163–234 (in Russian).Рабухин А.Е., Доброхотова М.Н., Тонитрова Н.С. Саркоидоз. М., Медицина; 1975.Rabukhin A.E., Dobrokhotova M.N., Tonitrova N.S. [Sarcoidosis]. Moscow: Meditsina; 1975 (in Russian).Wanat K.A., Rosenbach M. Cutaneous sarcoidosis. Clin. Chest Med. 2015; 36 (4): 685–702. DOI: 10.1016/j.ccm.2015.08.010.Wanat K.A., Rosenbach M. Cutaneous sarcoidosis. Clin. Chest Med. 2015; 36 (4): 685–702. DOI: 10.1016/j.ccm.2015.08.010.Matsou A., Tsaousis K.T. Management of chronic ocular sarcoidosis: challenges and solutions. Clin. Ophthalmol. 2018; 12: 519–532. DOI: 10.2147/OPTH.S128949.Matsou A., Tsaousis K.T. Management of chronic ocular sarcoidosis: challenges and solutions. Clin. Ophthalmol. 2018; 12: 519–532. DOI: 10.2147/OPTH.S128949.Judson M.A. The clinical features of sarcoidosis: a comprehensive review. Clin. Rev. Allergy Immunol. 2015; 49 (1): 63–78. DOI: 10.1007/s12016-014-8450-y.Judson M.A. The clinical features of sarcoidosis: a comprehensive review. Clin. Rev. Allergy Immunol. 2015; 49 (1): 63–78. DOI: 10.1007/s12016-014-8450-y.Madaule S., Lauque D., Sailler L. et al. [Splenomegaly in sarcoidosis: clinical features and outcome. Analysis of 17 cases]. Rev. Med. Interne. 2004; 25 (5): 348–356. DOI: 10.1016/j.revmed.2003.11.007 (in French).Madaule S., Lauque D., Sailler L. et al. [Splenomegaly in sarcoidosis: clinical features and outcome. Analysis of 17 cases]. Rev. Med. Interne. 2004; 25 (5): 348–356. DOI: 10.1016/j.revmed.2003.11.007 (in French).Löffler C., Bergner R. [Sarcoidosis: renal manifestations]. Z. Rheumatol. 2017; 76 (5): 398–407. DOI: 10.1007/s00393-017-0301-9 (in German).Löffler C., Bergner R. [Sarcoidosis: renal manifestations]. Z. Rheumatol. 2017; 76 (5): 398–407. DOI: 10.1007/s00393-017-0301-9 (in German).Bechman K., Christidis D., Walsh S. et al. A review of the musculo-skeletal manifestations of sarcoidosis. Rheumatology (Oxford). 2018; 57 (5): 777–783. DOI: 10.1093/rheumatology/kex317.Bechman K., Christidis D., Walsh S. et al. A review of the musculo-skeletal manifestations of sarcoidosis. Rheumatology (Oxford). 2018; 57 (5): 777–783. DOI: 10.1093/rheumatology/kex317.Chapman M.N., Fujita A., Sung E.K. et al. Sarcoidosis in the head and neck: an illustrative review of clinical presentations and imaging findings. AJR Am. J. Roentgenol. 2017; 208 (1): 66–75. DOI: 10.2214/AJR.16.16058.Chapman M.N., Fujita A., Sung E.K. et al. Sarcoidosis in the head and neck: an illustrative review of clinical presentations and imaging findings. AJR Am. J. Roentgenol. 2017; 208 (1): 66–75. DOI: 10.2214/AJR.16.16058.Иванова Д.А., Борисов С.Е., Недоступ А.В., Паша С. Поражение сердца при саркоидозе: диагностика латентных и клинически проявляющихся форм. Врач. 2008; (10): 28–33. Доступно на: https://www.elibrary.ru/download/elibrary_12924028_48123605.pdfIvanova D.A., Borisov S.E., Nedostup A.V., Pasha S. [Heart damage in sarcoidosis: diagnosis of latent and clinically manifested forms]. Vrach. 2008; (10): 28–33. Available at: https://www.elibrary.ru/download/elibrary_12924028_48123605.pdf (in Russian).Dubrey S., Sharma R., Underwood R. et al. Sarcoidosis of the cardio-pulmonary systems. Clin. Med. (Lond.). 2016; 16 (1): 34–41. DOI: 10.7861/clinmedicine.16-1-34.Dubrey S., Sharma R., Underwood R. et al. Sarcoidosis of the cardio-pulmonary systems. Clin. Med. (Lond.). 2016; 16 (1): 34–41. DOI: 10.7861/clinmedicine.16-1-34.Суслина З.А., Кистенёв Б.А., Максимова М.Ю., Моргунов В.А. Нейросаркоидоз. М.: МЕДпресс-информ; 2009.Suslina Z.A., Kistenev B.A., Maksimova M.Yu., Morgunov V.A. [Neurosarcoidosis]. Moscow: MEDpress-inform; 2009 (in Russian).Ibitoye R.T., Wilkins A., Scolding N.J. Neurosarcoidosis: a clinical approach to diagnosis and management. J. Neurol. 2017; 264 (5): 1023–1028. DOI: 10.1007/s00415-016-8336-4.Ibitoye R.T., Wilkins A., Scolding N.J. Neurosarcoidosis: a clinical approach to diagnosis and management. J. Neurol. 2017; 264 (5): 1023–1028. DOI: 10.1007/s00415-016-8336-4.Stern B.J., Royal W. 3rd, Gelfand J.M. et al. Definition and consensus diagnostic criteria for neurosarcoidosis: from the neurosarcoidosis Consortium Consensus Group. JAMA Neurol. 2018; 75 (12): 1546–1553. DOI: 10.1001/jamaneurol.2018.2295.Stern B.J., Royal W. 3rd, Gelfand J.M. et al. Definition and consensus diagnostic criteria for neurosarcoidosis: from the neurosarcoidosis Consortium Consensus Group. JAMA Neurol. 2018; 75 (12): 1546–1553. DOI: 10.1001/jamaneurol.2018.2295.Block N.L., Kava B.R. Genitourinary sarcoidosis: an essential review for the practicing clinician. Indian J. Urol. 2017; 33 (1): 6–12. DOI: 10.4103/0970-1591.195724.Block N.L., Kava B.R. Genitourinary sarcoidosis: an essential review for the practicing clinician. Indian J. Urol. 2017; 33 (1): 6–12. DOI: 10.4103/0970-1591.195724.Ghrenassia E., Mekinian A., Chapelon-Albric C. et al. Digestive-tract sarcoidosis: French nationwide case-control study of 25 cases. Medicine (Baltimore). 2016; 95 (29): e4279. DOI: 10.1097/md.0000000000004279.Ghrenassia E., Mekinian A., Chapelon-Albric C. et al. Digestive-tract sarcoidosis: French nationwide case-control study of 25 cases. Medicine (Baltimore). 2016; 95 (29): e4279. DOI: 10.1097/md.0000000000004279.Sahu P., Sharma S., Sharma N. et al. Unusual clinical presentations in early-onset childhood sarcoidosis: a correlation or coincidence? J. Clin. Diagn. Res. 2017; 11 (8): WD01–03. DOI: 10.7860/JCDR/2017/27841.10389.Sahu P., Sharma S., Sharma N. et al. Unusual clinical presentations in early-onset childhood sarcoidosis: a correlation or coincidence? J. Clin. Diagn. Res. 2017; 11 (8): WD01–03. DOI: 10.7860/JCDR/2017/27841.10389.Fretzayas A., Moustaki M., Vougiouka O. The puzzling clinical spectrum and course of juvenile sarcoidosis. World J. Pediatr. 2011; 7 (2): 103–110. DOI: 10.1007/s12519-011-0261-0.Fretzayas A., Moustaki M., Vougiouka O. The puzzling clinical spectrum and course of juvenile sarcoidosis. World J. Pediatr. 2011; 7 (2): 103–110. DOI: 10.1007/s12519-011-0261-0.Николаев А.В. Сравнительная оценка показателей неспецифического, клеточного и гуморального иммунитета у больных туберкулезом и саркоидозом легких. Вестник Новгородского государственного университета. 2019; 115 (3): 36–41. DOI: 10.34680/2076-8052.2019.3(115).36-41Nikolaev A.V. [Comparative assessment of indicators of nonspecific, cellular and humoral immunity in patients with tuberculosis and pulmonary sarcoidosis]. Vestnik Novgorodskogo gosudarstvennogo universiteta. 2019; 115 (3): 36–41. DOI: 10.34680/2076-8052.2019.3(115).36-41 (in Russian).Hoffmann A. L., Milman N., Byg K. E. Childhood sarcoidosis in Denmark 1979–1994: incidence, clinical features and laboratory results at presentation in 48 children. Acta Paediatr. 2004; 93 (1): 30–36. DOI: 10.1080/08035250310007213.Hoffmann A. L., Milman N., Byg K. E. Childhood sarcoidosis in Denmark 1979–1994: incidence, clinical features and laboratory results at presentation in 48 children. Acta Paediatr. 2004; 93 (1): 30–36. DOI: 10.1080/08035250310007213.Kempisty A., Białas-Chromiec B., Borkowska D., Kuś J. Interferon gamma release assays based on M. tuberculosis-specific antigens in sarcoidosis patients. Pneumonol. Alergol. Pol. 2015; 83 (2): 126–134. DOI: 10.5603/PiAP.2015.0020.Kempisty A., Białas-Chromiec B., Borkowska D., Kuś J. Interferon gamma release assays based on M. tuberculosis-specific antigens in sarcoidosis patients. Pneumonol. Alergol. Pol. 2015; 83 (2): 126–134. DOI: 10.5603/PiAP.2015.0020.Gupta D., Kumar S., Aggarwal A.N. et al. Interferon gamma release assay (QuantiFERON-TB Gold in Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection. Sarcoidosis Vasc. Diffuse Lung Dis. 2011; 28 (2): 95–101. Available at: https://www.researchgate.net/publication/51834535_Interferon_gamma_release_assay_QuantiFERON-TB_Gold_In_Tube_in_patients_of_sarcoidosis_from_a_population_with_high_prevalence_of_tuberculosis_infectionGupta D., Kumar S., Aggarwal A.N. et al. Interferon gamma release assay (QuantiFERON-TB Gold in Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection. Sarcoidosis Vasc. Diffuse Lung Dis. 2011; 28 (2): 95–101. Available at: https://www.researchgate.net/publication/51834535_Interferon_gamma_release_assay_QuantiFERON-TB_Gold_In_Tube_in_patients_of_sarcoidosis_from_a_population_with_high_prevalence_of_tuberculosis_infectionNosal A., Schleissner L.A., Mishkin F.S., Lieberman J. Angiotensin-I-converting enzyme and gallium scan in noninvasive evaluation of sarcoidosis. Ann. Intern. Med. 1979; 90 (3): 328–331. DOI: 10.7326/0003-4819-90-3-328.Nosal A., Schleissner L.A., Mishkin F.S., Lieberman J. Angiotensin-I-converting enzyme and gallium scan in noninvasive evaluation of sarcoidosis. Ann. Intern. Med. 1979; 90 (3): 328–331. DOI: 10.7326/0003-4819-90-3-328.Baughman R.P., Shipley R., Eisentrout C.E. Predictive value of gallium scan, angiotensin-converting enzyme level, and bronchoalveolar lavage in two-year follow-up of pulmonary sarcoidosis. Lung. 1987; 165 (6): 371–377. DOI: 10.1007/bf02714452.Baughman R.P., Shipley R., Eisentrout C.E. Predictive value of gallium scan, angiotensin-converting enzyme level, and bronchoalveolar lavage in two-year follow-up of pulmonary sarcoidosis. Lung. 1987; 165 (6): 371–377. DOI: 10.1007/bf02714452.Abe S., Munakata M., Nishimura M. et al. Gallium-67 scintigraphy, bronchoalveolar lavage, and pathologic changes in patients with pulmonary sarcoidosis. Chest. 1984; 85 (5): 650–655. DOI: 10.1378/chest.85.5.650.Abe S., Munakata M., Nishimura M. et al. Gallium-67 scintigraphy, bronchoalveolar lavage, and pathologic changes in patients with pulmonary sarcoidosis. Chest. 1984; 85 (5): 650–655. DOI: 10.1378/chest.85.5.650.Okayama K., Kurata C., Tawarahara K. et al. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest. 1995; 107 (2): 330–334. DOI: 10.1378/chest.107.2.330.Okayama K., Kurata C., Tawarahara K. et al. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest. 1995; 107 (2): 330–334. DOI: 10.1378/chest.107.2.330.Bekerman C., Szidon J. P., Pinsky S. The role of gallium-67 in the clinical evaluation of sarcoidosis. Semin. Roentgenol. 1985; 20 (4): 400–409. DOI: 10.1016/0037-198x(85)90047-1.Bekerman C., Szidon J. P., Pinsky S. The role of gallium-67 in the clinical evaluation of sarcoidosis. Semin. Roentgenol. 1985; 20 (4): 400–409. DOI: 10.1016/0037-198x(85)90047-1.Jerusalem G., Beguin Y., Fassotte M.F. et al. Whole-body positron emission tomography using18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin’s disease and non-Hodgkin’s lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood. 1999; 94 (2): 429–433. Available at: https://www.researchgate.net/publication/12077850_Whole-body_positron_emission_tomography_using_18F-fluorodeoxyglucose_compared_to_standard_procedures_for_staging_patients_with_Hodgkins_diseaseJerusalem G., Beguin Y., Fassotte M.F. et al. Whole-body positron emission tomography using18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin’s disease and non-Hodgkin’s lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood. 1999; 94 (2): 429–433. Available at: https://www.researchgate.net/publication/12077850_Whole-body_positron_emission_tomography_using_18F-fluorodeoxyglucose_compared_to_standard_procedures_for_staging_patients_with_Hodgkins_diseaseOzer O., Eskazan A.E., Ar M.C. et al. Sarcoidosis mimicking lymphoma on positron emission tomography-computed tomography in two patients treated for lymphoma: two case reports. J. Med. Case Rep. 2009; 3: 7306. DOI: 10.4076/1752-1947-3-7306.Ozer O., Eskazan A.E., Ar M.C. et al. Sarcoidosis mimicking lymphoma on positron emission tomography-computed tomography in two patients treated for lymphoma: two case reports. J. Med. Case Rep. 2009; 3: 7306. DOI: 10.4076/1752-1947-3-7306.Dziedzic D.A., Peryt A., Orlowski T. The role of EBUS-TBNA and standard bronchoscopic modalities in the diagnosis of sarcoidosis. Clin. Respir. J. 2017; 11 (1): 58–63. DOI: 10.1111/crj.12304.Dziedzic D.A., Peryt A., Orlowski T. The role of EBUS-TBNA and standard bronchoscopic modalities in the diagnosis of sarcoidosis. Clin. Respir. J. 2017; 11 (1): 58–63. DOI: 10.1111/crj.12304.Millward K., Fiddler C.A., Thillai M. Update on sarcoidosis guidelines. Curr. Opin. Pulm. Med. 2021; 27 (5): 484–489. DOI: 10.1097/MCP.0000000000000807.Millward K., Fiddler C.A., Thillai M. Update on sarcoidosis guidelines. Curr. Opin. Pulm. Med. 2021; 27 (5): 484–489. DOI: 10.1097/MCP.0000000000000807.Demir O.F., Onal O. Is mediastinoscopy an effective diagnostic method in mediastinal area evaluation in pediatric patients? Asian. J. Surg. 2020; 43 (6): 690–695. DOI: 10.1016/j.asjsur.2019.09.012.Demir O.F., Onal O. Is mediastinoscopy an effective diagnostic method in mediastinal area evaluation in pediatric patients? Asian. J. Surg. 2020; 43 (6): 690–695. DOI: 10.1016/j.asjsur.2019.09.012.Yoon H.Y., Kim H.M., Kim Y.J., Song J.W. Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study. Respir. Res. 2018; 19 (1): 158. DOI: 10.1186/s12931-018-0871-3.Yoon H.Y., Kim H.M., Kim Y.J., Song J.W. Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study. Respir. Res. 2018; 19 (1): 158. DOI: 10.1186/s12931-018-0871-3.Verleden S.E., Vanstapel A., De Sadeleer L. et al. Distinct airway involvement in subtypes of end-stage fibrotic pulmonary sarcoidosis. Chest. 2021; 160 (2): 562–571. DOI: 10.1016/j.chest.2021.01.003.Verleden S.E., Vanstapel A., De Sadeleer L. et al. Distinct airway involvement in subtypes of end-stage fibrotic pulmonary sarcoidosis. Chest. 2021; 160 (2): 562–571. DOI: 10.1016/j.chest.2021.01.003.Khan T., Selvakumar D., Trivedi S. et al. The value of endomyocardial biopsy in diagnosis and guiding therapy. Pathology. 2017; 49 (7): 750–756. DOI: 10.1016/j.pathol.2017.08.004.Khan T., Selvakumar D., Trivedi S. et al. The value of endomyocardial biopsy in diagnosis and guiding therapy. Pathology. 2017; 49 (7): 750–756. DOI: 10.1016/j.pathol.2017.08.004.Zhang C., Chan K.M., Schmidt L.A., Myers J.L. Histopathology of explanted lungs from patients with a diagnosis of pulmonary sarcoidosis. Chest. 2016; 149 (2): 499–507. DOI: 10.1378/chest.15-0615.Zhang C., Chan K.M., Schmidt L.A., Myers J.L. Histopathology of explanted lungs from patients with a diagnosis of pulmonary sarcoidosis. Chest. 2016; 149 (2): 499–507. DOI: 10.1378/chest.15-0615.Buxbaum J., Papademetriou M., Klipfel N. et al. Biliary sarcoidosis: early diagnosis minimizes the need for surgery. Am. J. Respir. Crit. Care Med. 2013; 187 (5): 556–559. DOI: 10.1164/ajrccm.187.5.556.Buxbaum J., Papademetriou M., Klipfel N. et al. Biliary sarcoidosis: early diagnosis minimizes the need for surgery. Am. J. Respir. Crit. Care Med. 2013; 187 (5): 556–559. DOI: 10.1164/ajrccm.187.5.556.Siavelis H.A., Herrmann M.E., Aranha G.V. et al. Sarcoidosis and the pancreas. Surgery. 1999; 125 (4): 456–461. DOI: 10.1016/S0039-6060(99)70014-0.Siavelis H.A., Herrmann M.E., Aranha G.V. et al. Sarcoidosis and the pancreas. Surgery. 1999; 125 (4): 456–461. DOI: 10.1016/S0039-6060(99)70014-0.Manchanda A., Patel S., Jiang J.J., Babu A.R. Thyroid: an unusual hideout for sarcoidosis. Endocr. Pract. 2013; 19 (2): e40–43. DOI: 10.4158/EP12131.CR.Manchanda A., Patel S., Jiang J.J., Babu A.R. Thyroid: an unusual hideout for sarcoidosis. Endocr. Pract. 2013; 19 (2): e40–43. DOI: 10.4158/EP12131.CR.James D.G., Jones Williams W., eds. Sarcoidosis and other granulomatous disorders. Philadelphia: Saunders; 1985: 163–166. DOI: 10.1002/PPUL.1950010513.James D.G., Jones Williams W., eds. Sarcoidosis and other granulomatous disorders. Philadelphia: Saunders; 1985: 163–166. DOI: 10.1002/PPUL.1950010513.Шмелев Е.И. Дифференциальная диагностика диссеминированных заболеваний легких неопухолевой природы. Русский медицинский журнал. 2001; (21): 919–922. Доступно на: https://www.rmj.ru/articles/bolezni_dykhatelnykh_putey/Differencialynaya_diagnostika_disseminirovannyh_zabolevaniy_legkih_neopuholevoy_prirody/Shmelev E.I. [Differential diagnosis of disseminated diseases of the lungs of a non-tumor nature]. Russkiy meditsinskiy zhurnal. 2001; (21): 918–922. Available at: https://www.rmj.ru/articles/bolezni_dykhatelnykh_putey/Differencialynaya_diagnostika_disseminirovannyh_zabolevaniy_legkih_neopuholevoy_prirody/ (in Russian).El Sayed F., Torbey G., Youssef H., Chababi M. Childhood sarcoidosis: diagnostic issues. Dermatol. Online J. 2013; 19 (10): 20037. DOI: 10.5070/D31910020037.El Sayed F., Torbey G., Youssef H., Chababi M. Childhood sarcoidosis: diagnostic issues. Dermatol. Online J. 2013; 19 (10): 20037. DOI: 10.5070/D31910020037.Deverrière G., Flamans-Klein A., Firmin D. et al. [Early onset pediatric sarcoidosis, diagnostic problems]. Arch. Pediatr. 2012; 19 (7): 707–710. DOI: 10.1016/j.arcped.2012.04.024.Deverrière G., Flamans-Klein A., Firmin D. et al. [Early onset pediatric sarcoidosis, diagnostic problems]. Arch. Pediatr. 2012; 19 (7): 707–710. DOI: 10.1016/j.arcped.2012.04.024.Bradley B., Branley H.M., Egan J.J. et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008; 63: v1–58. DOI: 10.1136/thx.2008.101691.Bradley B., Branley H.M., Egan J.J. et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008; 63: v1–58. DOI: 10.1136/thx.2008.101691.Baughman R., Drent M., Judson M. et al. Sarcoidosis treatment guidelines. Available at: https://stopsarcoidosis.org/wp-content/uploads/2013/03/FSR-Physicians-Protocol1.pdfBaughman R., Drent M., Judson M. et al. Sarcoidosis treatment guidelines. Available at: https://stopsarcoidosis.org/wp-content/uploads/2013/03/FSR-Physicians-Protocol1.pdfBalasubramanian A., Wade S.W., Adler R.A. et al. Glucocorticoid exposure and fracture risk in a cohort of US patients with selected conditions. J. Bone Miner Res. 2018; 33 (10): 1881–1888. DOI: 10.1002/jbmr.3523.Balasubramanian A., Wade S.W., Adler R.A. et al. Glucocorticoid exposure and fracture risk in a cohort of US patients with selected conditions. J. Bone Miner Res. 2018; 33 (10): 1881–1888. DOI: 10.1002/jbmr.3523.James W.E., Baughman R. Treatment of sarcoidosis: grading the evidence. Expert Rev. Clin. Pharmacol. 2018; 11 (7): 677–687. DOI: 10.1080/17512433.2018.1486706.James W.E., Baughman R. Treatment of sarcoidosis: grading the evidence. Expert Rev. Clin. Pharmacol. 2018; 11 (7): 677–687. DOI: 10.1080/17512433.2018.1486706.Baughman R.P., Nunes H., Sweiss N.J. et al. Established and experimental medical therapy of pulmonary sarcoidosis. Eur. Respir. J. 2013; 41 (6): 1424–1438. DOI: 10.1183/09031936.00060612.Baughman R.P., Nunes H., Sweiss N.J. et al. Established and experimental medical therapy of pulmonary sarcoidosis. Eur. Respir. J. 2013; 41 (6): 1424–1438. DOI: 10.1183/09031936.00060612.Soto-Gomez N., Peters J.I., Nambiar A.M. Diagnosis and management of sarcoidosis. Am. Fam. Physician. 2016; 93 (10): 840–850. https://www.aafp.org/pubs/afp/issues/2016/0515/p840.htmlSoto-Gomez N., Peters J.I., Nambiar A.M. Diagnosis and management of sarcoidosis. Am. Fam. Physician. 2016; 93 (10): 840–850. https://www.aafp.org/pubs/afp/issues/2016/0515/p840.htmlВизель А. А., Калвер Д. А., Визель И. Ю. и др. Оценка влияния альфа-токоферола на течение впервые выявленного саркоидоза легких: сравнительное исследование. Туберкулез и болезни легких. 2020; 98 (10): 33–40. DOI: 10.21292/2075-1230-2020-98-10-33-40.Vizel’ A. A., Kalver D. A., Vizel’ I. Ju. et al. [Assessment of the effect of alpha-tocopherol on the course of newly diagnosed pulmonary sarcoidosis: a comparative study]. Tuberkulyoz i bolezni lyogkih. 2020; 98 (10): 33–40. DOI: 10.21292/2075-1230-2020-98-10-33-40 (in Russian).Костина З.И. О результатах лечения саркоидоза легких. Проблемы туберкулеза. 1977; (8): 44–50.Kostina Z.I. [Results of treatment of sarcoidosis of the lungs]. Problemy tuberkuleza. 1977; (8): 44–50 (in Russian).Diallo B.D., Diot B., Flament T. et al. [The pentoxifylline, a corticosteroid sparing in the treatment of sarcoidosis: a case report]. Rev. Pneumol. Clin. 2018; 74 (1): 48–51. DOI: 10.1016/j.pneumo.2017.08.014.Diallo B.D., Diot B., Flament T. et al. [The pentoxifylline, a corticosteroid sparing in the treatment of sarcoidosis: a case report]. Rev. Pneumol. Clin. 2018; 74 (1): 48–51. DOI: 10.1016/j.pneumo.2017.08.014.Refiskaya N.V., Stepanenko T.A., Jablonskiy P.K., Baranova O.P. The use of tumor necrosis factor alpha inhibitor pentoxifylline in the treatment of patients with I and II stages of pulmonary sarcoidosis. Eur. Respir. J. 2006; 28 (Suppl. 50): E3134. Available at: https://www.ers-education.org/lr/show-details/?idP=8337Refiskaya N.V., Stepanenko T.A., Jablonskiy P.K., Baranova O.P. The use of tumor necrosis factor alpha inhibitor pentoxifylline in the treatment of patients with I and II stages of pulmonary sarcoidosis. Eur. Respir. J. 2006; 28 (Suppl. 50): E3134. Available at: https://www.ers-education.org/lr/show-details/?idP=8337Визель А.А., Визель Е.А., Насретдинова Г.Р. и др. Оценка эффективности малых доз пентоксифиллина в сочетании с токоферола ацетатом при внутригрудном саркоидозе. Пульмонология. 2005; (1): 24–28. DOI: 10.18093/0869-0189-2005-0-1-24-28.Vizel A.A., Vizel E.A., Nasretdinova G.R. et al. [Effectiveness of low-dose pentoxithylline combined with tocopherol acetate in intrathoracic sacroidosis]. Pul’monologiya. 2005; (1): 24–28. DOI: 10.18093/0869-0189-2005-0-1-24-28 (in Russian).Crommelin H.A., Vorselaars A.D., van Moorsel C.H. et al. Anti-TNF therapeutics for the treatment of sarcoidosis. Immunotherapy. 2014; 6 (10): 1127–1143. DOI: 10.2217/imt.14.65.Crommelin H.A., Vorselaars A.D., van Moorsel C.H. et al. Anti-TNF therapeutics for the treatment of sarcoidosis. Immunotherapy. 2014; 6 (10): 1127–1143. DOI: 10.2217/imt.14.65.О совершенствовании санаторно-курортной и реабилитационной помощи больным туберкулезом. Приказ Минздравмедпрома РФ № 291 от 19.07.96 Доступно на: https://tkrfkod.ru/zakonodatelstvo/prikaz-minzdravmedproma-rf-ot-19071996-n-291/About improvement of the sanatorium-resort and rehabilitation help to patients with tuberculosis. Order of the Ministry of Health and Medical Industry of the Russian Federation No.291 (July 19, 1996)]. Available at: https://tkrfkod.ru/zakonodatelstvo/prikaz-minzdravmedproma-rf-ot-19071996-n-291/ (in Russian).Визель А.А., Гурылева М.Э. Саркоидоз у детей. Педиатрия. Журнал имени Г.Н.Сперанского. 2004; 83 (2): 62–66. Доступно на: https://pediatriajournal.ru/files/upload/mags/263/2004_2_1177.pdfVizel’ A.A., Guryleva M.Ye. [Sarcoidosis in children]. Pediatriya. Zhurnal imeni G.N.Speranskogo. 2004; 83 (2): 62–66. Available at: https://pediatriajournal.ru/files/upload/mags/263/2004_2_1177.pdf (in Russian).Paramothayan N., Lasserson T., Jones P. Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst. Rev. 2005; (2): CD001114. DOI: 10.1002/14651858.cd001114.pub2.Paramothayan N., Lasserson T., Jones P. Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst. Rev. 2005; (2): CD001114. DOI: 10.1002/14651858.cd001114.pub2.ГРЛС. Преднизолон: регистрационное удостоверение. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=5bb36449-e307-43d1-ad5a-7171d992c66a&t=State Register of Medicines. Prednisolone. Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=5bb36449-e307-43d1-ad5a-7171d992c66a&t= (in Russian).Milman N., Hoffmann A. L., Byg K. E. Sarcoidosis in children. Epidemiology in Danes, clinical features, diagnosis, treatment and prognosis. Acta Paediatrica.1998; 87 (8): 871–878. DOI: 10.1080/080352598750013662.Milman N., Hoffmann A. L., Byg K. E. Sarcoidosis in children. Epidemiology in Danes, clinical features, diagnosis, treatment and prognosis. Acta Paediatrica.1998; 87 (8): 871–878. DOI: 10.1080/080352598750013662.Adami G., Saag K.G. Glucocorticoid-induced osteoporosis: 2019 concise clinical review. Osteoporos Int. 2019; 30 (6): 1145–1156. DOI: 10.1007/s00198-019-04906-x.Adami G., Saag K.G. Glucocorticoid-induced osteoporosis: 2019 concise clinical review. Osteoporos Int. 2019; 30 (6): 1145–1156. DOI: 10.1007/s00198-019-04906-x.Scherholz M.L., Schlesinger N., Androulakis I.P. Chronopharmacology of glucocorticoids. Adv. Drug Deliv. Rev. 2019. 151–152; 245–261. DOI: 10.1016/j.addr.2019.02.004.Scherholz M.L., Schlesinger N., Androulakis I.P. Chronopharmacology of glucocorticoids. Adv. Drug Deliv. Rev. 2019. 151–152; 245–261. DOI: 10.1016/j.addr.2019.02.004.Dinsen S., Baslund B., Klose M. et al. Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself. Eur. J. Intern. Med. 2013; 24 (8): 714–720. DOI: 10.1016/j.ejim.2013.05.014.Dinsen S., Baslund B., Klose M. et al. Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself. Eur. J. Intern. Med. 2013; 24 (8): 714–720. DOI: 10.1016/j.ejim.2013.05.014.Coker R. K. Guidelines for the use of corticosteroids in the treatment of pulmonary sarcoidosis. Drugs. 2007; 67 (8): 1139–1147. DOI: 10.2165/00003495-200767080-00004.Coker R. K. Guidelines for the use of corticosteroids in the treatment of pulmonary sarcoidosis. Drugs. 2007; 67 (8): 1139–1147. DOI: 10.2165/00003495-200767080-00004.Herlow L.B., Rasmussen N. [Laryngeal sarcoidosis in 13 year-old teenager]. Ugeskr. Laeger. 2010; 172 (45): 3116–3117. Available at: https://ugeskriftet.dk/files/scientific_article_files/2014-04//artikel_8769.pdf (in Danish).Herlow L.B., Rasmussen N. [Laryngeal sarcoidosis in 13 year-old teenager]. Ugeskr. Laeger. 2010; 172 (45): 3116–3117. Available at: https://ugeskriftet.dk/files/scientific_article_files/2014-04//artikel_8769.pdf (in Danish).ГРЛС. Метотрексат: регистрационное удостоверение. Доступно на: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=43da4be2-b2bc-4eaa-8031-aae6250bf870&t=State Register of Medicines. Methotrexate. Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=43da4be2-b2bc-4eaa-8031-aae6250bf870&t= (in Russian).Cremers J.P., Drent M., Bast A. et al. Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide. Curr. Opin. Pulm. Med. 2013; 19 (5): 545–561. DOI: 10.1097/mcp.0b013e3283642a7a.Cremers J.P., Drent M., Bast A. et al. Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide. Curr. Opin. Pulm. Med. 2013; 19 (5): 545–561. DOI: 10.1097/mcp.0b013e3283642a7a.Гаврисюк В., Меренкова Е., Гуменюк Г. и др. Эффективность и безопасность монотерапии метотрексатом у пациентов с саркоидозом легких. Georgian Med. News. 2018; (283): 34–38. Доступно на: https://geomednews.com/s/480918712df344a4a77508d4cd7815ab/files/uploaded/V283_N10_October_2018.pdf?Gavrysyuk V., Merenkova E., Gumeniuk G. et al. [Effectiveness and safety of methotrexate monotherapy in patients with pulmonary sarcoidosis]. Georgian Med. News. 2018; (283): 34–38. Available at: https://geomednews.com/s/480918712df344a4a77508d4cd7815ab/files/uploaded/V283_N10_October_2018.pdf? (in Russian).Baughman R.P., Winget D.B., Lower E.E. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc. Diffuse Lung Dis. 2000; 17 (1): 60–66. Available at: https://read.qxmd.com/read/10746262/methotrexate-is-steroid-sparing-in-acute-sarcoidosis-results-of-a-double-blind-randomized-trialBaughman R.P., Winget D.B., Lower E.E. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc. Diffuse Lung Dis. 2000; 17 (1): 60–66. Available at: https://read.qxmd.com/read/10746262/methotrexate-is-steroid-sparing-in-acute-sarcoidosis-results-of-a-double-blind-randomized-trialВизель А.А., Визель И.Ю. Применение метотрексата при саркоидозе (по данным контролируемого проспективного исследования). Клиническая медицина. 2015; 93 (1): 41–46. Доступно на: https://cyberleninka.ru/article/n/primenenie-metotreksata-pri-sarkoidoze-po-dannym-kontroliruemogo-prospektivnogo-issledovaniya/viewerVizel’ A.A., Vizel’ I.Ju. [The use of methotrexate in sarcoidosis (according to a controlled prospective study)]. Klinicheskaya meditsina. 2015; 93 (1): 41–46. Available at: https://cyberleninka.ru/article/n/primenenie-metotreksata-pri-sarkoidoze-po-dannym-kontroliruemogo-prospektivnogo-issledovaniya/viewer (in Russian).Gedalia A., Molina J.F., Ellis G.S. Jr. et al. Low-dose methotrexate therapy for childhood sarcoidosis. J. Pediatr. 1997; 130 (1): 25–29. DOI: 10.1016/s0022-3476(97)70306-8.Gedalia A., Molina J.F., Ellis G.S. Jr. et al. Low-dose methotrexate therapy for childhood sarcoidosis. J. Pediatr. 1997; 130 (1): 25–29. DOI: 10.1016/s0022-3476(97)70306-8.Gedalia A., Khan T.A., Shetty A.K. et al. Childhood sarcoidosis: Louisiana experience. Clin. Rheumatol. 2016; 35 (7): 1879–1884. DOI: 10.1007/s10067-015-2870-9.Gedalia A., Khan T.A., Shetty A.K. et al. Childhood sarcoidosis: Louisiana experience. Clin. Rheumatol. 2016; 35 (7): 1879–1884. DOI: 10.1007/s10067-015-2870-9.Birnie D., Beanlands R.S.B., Nery P. et al. Cardiac sarcoidosis multi-center randomized controlled trial (CHASM CS-RCT). Am. Heart J. 2020; 220: 246–252. DOI: 10.1016/j.ahj.2019.10.003.Birnie D., Beanlands R.S.B., Nery P. et al. Cardiac sarcoidosis multi-center randomized controlled trial (CHASM CS-RCT). Am. Heart J. 2020; 220: 246–252. DOI: 10.1016/j.ahj.2019.10.003.Ning N., Guo H.H., Iagaru A. et al. Serial cardiac FDG-PET for the diagnosis and therapeutic guidance of patients with cardiac sarcoidosis. J. Card. Fail. 2019; 25 (4): 307–311. DOI: 10.1016/j.cardfail.2019.02.018.Ning N., Guo H.H., Iagaru A. et al. Serial cardiac FDG-PET for the diagnosis and therapeutic guidance of patients with cardiac sarcoidosis. J. Card. Fail. 2019; 25 (4): 307–311. DOI: 10.1016/j.cardfail.2019.02.018.Soriano F. G., Caramelli P., Nitrini R., Rocha A.S. Neurosarcoidosis: therapeutic success with methotrexate. Postgrad. Med. J. 1990; 66 (772): 142–143. DOI: 10.1136/pgmj.66.772.142.Soriano F. G., Caramelli P., Nitrini R., Rocha A.S. Neurosarcoidosis: therapeutic success with methotrexate. Postgrad. Med. J. 1990; 66 (772): 142–143. DOI: 10.1136/pgmj.66.772.142.Judson M. A. Sarcoidosis: clinical presentation, diagnosis, and approach to treatment. Am. J. Med. Sci. 2008; 335 (1): 26–33. DOI: 10.1097/maj.0b013e31815d8276.Judson M. A. Sarcoidosis: clinical presentation, diagnosis, and approach to treatment. Am. J. Med. Sci. 2008; 335 (1): 26–33. DOI: 10.1097/maj.0b013e31815d8276.Vorselaars A.D., Cremers J.P., Grutters J.C., Drent M. Cytotoxic agents in sarcoidosis: which one should we choose? Curr. Opin. Pulm. Med. 2014; 20 (5): 479–487. DOI: 10.1097/mcp.0000000000000078.Vorselaars A.D., Cremers J.P., Grutters J.C., Drent M. Cytotoxic agents in sarcoidosis: which one should we choose? Curr. Opin. Pulm. Med. 2014; 20 (5): 479–487. DOI: 10.1097/mcp.0000000000000078.Ballul T., Borie R., Crestani B. et al. Treatment of cardiac sarcoidosis: a comparative study of steroids and steroids plus immunosuppressive drugs. Int. J. Cardiol. 2019; 276: 208–211. DOI: 10.1016/j.ijcard.2018.11.131.Ballul T., Borie R., Crestani B. et al. Treatment of cardiac sarcoidosis: a comparative study of steroids and steroids plus immunosuppressive drugs. Int. J. Cardiol. 2019; 276: 208–211. DOI: 10.1016/j.ijcard.2018.11.131.Lewis S.J., Ainslie G.M., Bateman E.D. Efficacy of azathioprine as second-line treatment in pulmonary sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 1999; 16 (1): 87–92. Available at: https://www.semanticscholar.org/paper/Efficacy-of-azathioprine-as-second-line-treatment-Lewis-Ainslie/f8f6fe3938be432c3d49af53d4d8fcacac308453Lewis S.J., Ainslie G.M., Bateman E.D. Efficacy of azathioprine as second-line treatment in pulmonary sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 1999; 16 (1): 87–92. Available at: https://www.semanticscholar.org/paper/Efficacy-of-azathioprine-as-second-line-treatment-Lewis-Ainslie/f8f6fe3938be432c3d49af53d4d8fcacac308453Beegle S.H., Barba K., Gobunsuy R., Judson M.A. Current and emerging pharmacological treatments for sarcoidosis: a review. Drug Des. Devel. Ther. 2013; 7: 325–328. DOI: 10.2147/dddt.s31064.Beegle S.H., Barba K., Gobunsuy R., Judson M.A. Current and emerging pharmacological treatments for sarcoidosis: a review. Drug Des. Devel. Ther. 2013; 7: 325–328. DOI: 10.2147/dddt.s31064.ГРЛС. Азатиоприн: регистрационное удостоверение Доступно на: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=186056b6-254d-44c1-a1c8-aac7f595a198&t=State Register of Medicines. Azathioprine. Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=186056b6-254d-44c1-a1c8-aac-7f595a198&t= (in Russian).El Jammal T., Jamilloux Y., Gerfaud-Valentin M. et al. Refractory sarcoidosis: a review. Ther. Clin. Risk. Manag. 2020; 16: 323–345. DOI: 10.2147/TCRM.S192922.El Jammal T., Jamilloux Y., Gerfaud-Valentin M. et al. Refractory sarcoidosis: a review. Ther. Clin. Risk. Manag. 2020; 16: 323–345. DOI: 10.2147/TCRM.S192922.Baughman R.P., Lower E.E. Leflunomide for chronic sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2004; 21 (1): 43–48. DOI: 10.1007/s11083-004-5178-y.Baughman R.P., Lower E.E. Leflunomide for chronic sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2004; 21 (1): 43–48. DOI: 10.1007/s11083-004-5178-y.Raj R., Nugent K. Leflunomide-induced interstitial lung disease (a systematic review). Sarcoidosis Vasc. Diffuse Lung Dis. 2013; 30 (3): 167–176. Available at: https://www.researchgate.net/publication/258957656_Leflunomide-induced_interstitial_lung_disease_a_systematic_reviewRaj R., Nugent K. Leflunomide-induced interstitial lung disease (a systematic review). Sarcoidosis Vasc. Diffuse Lung Dis. 2013; 30 (3): 167–176. Available at: https://www.researchgate.net/publication/258957656_Leflunomide-induced_interstitial_lung_disease_a_systematic_reviewBohelay G., Bouaziz J.D., Nunes H. et al. Striking leflunomide efficacy against refractory cutaneous sarcoidosis. J. Am. Acad. Dermatol. 2014; 70 (5): e111–113. DOI: 10.1016/j.jaad.2013.10.048.Bohelay G., Bouaziz J.D., Nunes H. et al. Striking leflunomide efficacy against refractory cutaneous sarcoidosis. J. Am. Acad. Dermatol. 2014; 70 (5): e111–113. DOI: 10.1016/j.jaad.2013.10.048.Sahoo D.H., Bandyopadhyay D., Xu M. et al. Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis. Eur. Respir. J. 2011; 38 (5): 1145–1150. DOI: 10.1183/09031936.00195010.Sahoo D.H., Bandyopadhyay D., Xu M. et al. Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis. Eur. Respir. J. 2011; 38 (5): 1145–1150. DOI: 10.1183/09031936.00195010.ГРЛС. Арресто: регистрационное удостоверение Доступно на: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=46c1c8dd-0c2e-48b0-bf3e-be5a206a1238&t=State Register of Medicines. Arresto. Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=46c1c8dd-0c2e-48b0-bf3e-be5a206a1238&t= (in Russian).Hamzeh N., Voelker A., Forssen A. et al. Efficacy of mycophenolate mofetil in sarcoidosis. Respir. Med. 2014; 108 (11): 1663–1669. DOI: 10.1016/j.rmed.2014.09.013.Hamzeh N., Voelker A., Forssen A. et al. Efficacy of mycophenolate mofetil in sarcoidosis. Respir. Med. 2014; 108 (11): 1663–1669. DOI: 10.1016/j.rmed.2014.09.013.Мухин Н.А., ред. Саркоидоз: клинические рекомендации. М.: ИМА-ПРЕСС; 2009.Muhin N.A., ed. [Sarcoidosis: clinical guidelines]. Moscow: IMA-PRESS; 2009 (in Russian).Kikuchi N., Nunoda S., Serizawa N. et al. Combination therapy with corticosteroid and mycophenolate mofetil in a case of refractory cardiac sarcoidosis. J. Cardiol. Cases. 2016; 13 (4): 125–128. DOI: 10.1016/j.jccase.2015.12.008.Kikuchi N., Nunoda S., Serizawa N. et al. Combination therapy with corticosteroid and mycophenolate mofetil in a case of refractory cardiac sarcoidosis. J. Cardiol. Cases. 2016; 13 (4): 125–128. DOI: 10.1016/j.jccase.2015.12.008.ГРЛС. Фломирен: регистрационное удостоверение. Доступно на: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=9fd35729-ab22-4b2c-a80d-41619164b8b2&t=State Register of Medicines. Flomiren. Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=9fd35729-ab22-4b2c-a80d-41619164b8b2&t= (in Russian).Moudgil A., Przygodzki R. M., Kher K. K. Successful steroid-sparing treatment of renal limited sarcoidosis with mycophenolate mofetil. Pediatr. Nephrol. 2006; 21 (2): 281–285. DOI: 10.1007/s00467-005-2086-3.Moudgil A., Przygodzki R. M., Kher K. K. Successful steroid-sparing treatment of renal limited sarcoidosis with mycophenolate mofetil. Pediatr. Nephrol. 2006; 21 (2): 281–285. DOI: 10.1007/s00467-005-2086-3.Judson M. A. Sarcoidosis: clinical presentation, diagnosis, and approach to treatment. Am. J. Med. Sci. 2008; 335 (1): 26–33. DOI: 10.1097/maj.0b013e31815d8276.Judson M. A. Sarcoidosis: clinical presentation, diagnosis, and approach to treatment. Am. J. Med. Sci. 2008; 335 (1): 26–33. DOI: 10.1097/maj.0b013e31815d8276.ГРЛС. Эндоксан: регистрационное удостоверение. Доступно на: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=cc8c311d-6bae-4a30-b1d2-f4e74e5f3644&tState Register of Medicines. Endoxan. Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=cc8c311d-6bae-4a30-b1d2-f4e74e5f3644&t (in Russian).Rabinowitz M.P., Murchison A.P. Orbital sarcoidosis treated with hydroxychloroquine. Orbit. 2011; 30 (1): 13–15. DOI: 10.3109/01676830.2010.524268.Rabinowitz M.P., Murchison A.P. Orbital sarcoidosis treated with hydroxychloroquine. Orbit. 2011; 30 (1): 13–15. DOI: 10.3109/01676830.2010.524268.Kiedrowicz M., Kacalak-Rzepka A., Bielecka-Grzela S., Maleszka R. [Antimalarial drugs in contemporary dermatologic therapy]. Ann. Acad. Med. Stetin. 2011; 57 (1): 38–44. Available at: https://www.researchgate.net/publication/224975968_Antimalarial_drugs_in_contemporary_dermatologic_therapyKiedrowicz M., Kacalak-Rzepka A., Bielecka-Grzela S., Maleszka R. [Antimalarial drugs in contemporary dermatologic therapy]. Ann. Acad. Med. Stetin. 2011; 57 (1): 38–44. Available at: https://www.researchgate.net/publication/224975968_Antimalarial_drugs_in_contemporary_dermatologic_therapyГРЛС. Плаквенил: регистрационное удостоверение. Доступно на: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=92eff6a5-c78c-4d28-910b-cdcc78986307&t=State Register of Medicines. Plaquenil. Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=92eff6a5-c78c-4d28-910b-cdc-c78986307&t= (in Russian).Baltzan M., Mehta S., Kirkham T.H., Cosio M.G. Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 1999; 160 (1): 192–197. DOI: 10.1164/ajrccm.160.1.9809024.Baltzan M., Mehta S., Kirkham T.H., Cosio M.G. Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 1999; 160 (1): 192–197. DOI: 10.1164/ajrccm.160.1.9809024.Zabel P., Entzian P., Dalhoff K., Schlaak M. Pentoxifylline in treatment of sarcoidosis. Am. J. Respir. Crit. Care Med. 1997; 155 (5): 1665–1669. DOI: 10.1164/ajrccm.155.5.9154873.Zabel P., Entzian P., Dalhoff K., Schlaak M. Pentoxifylline in treatment of sarcoidosis. Am. J. Respir. Crit. Care Med. 1997; 155 (5): 1665–1669. DOI: 10.1164/ajrccm.155.5.9154873.Park M.K., Fontana Jr., Babaali H. et al. Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2009; 26 (2): 121–131. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946799/Park M.K., Fontana Jr., Babaali H. et al. Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2009; 26 (2): 121–131. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946799/Popova E.N., Bolevich S.B., Fomin V.V. et al. Pulmonary hypertension associated with sarcoidosis and experience of treatment with pentoxifylline (Vasonite). Eur. Respir. J. 2006; 28 (Suppl. 50): 2491. Available at: https://www.ers-education.org/lr/show-details/?idP=7643Popova E.N., Bolevich S.B., Fomin V.V. et al. Pulmonary hypertension associated with sarcoidosis and experience of treatment with pentoxifylline (Vasonite). Eur. Respir. J. 2006; 28 (Suppl. 50): 2491. Available at: https://www.ers-education.org/lr/show-details/?idP=7643Бородина Г.Л. Антицитокиновая терапия пентоксифиллином в виде монотерапии и в сочетании с глюкокортикостероидами при саркоидозе органов дыхания. Туберкулз и болезни легких. 2013; (8): 15–20. Доступно на: https://www.elibrary.ru/download/elibrary_20658497_99153726.pdfBorodina G.L. [Anticytokine therapy with pentoxifylline as monotherapy and in combination with glucocorticosteroids in respiratory sarcoidosis]. Tuberkulez i bolezni legkikh. 2013; (8): 15–20. Available at: https://www.elibrary.ru/download/elibrary_20658497_99153726.pdf (in Russian).Костина З.И., Браженко Н.А., Насорина Р.Н. Отдаленные результаты наблюдения за леченными больными саркоидозом органов дыхания. Проблемы туберкулеза. 1995; (3): 34–37.Kostina Z.I., Brazhenko N.A., Nasorina R.N. [Long-term results of observation of treated patients with respiratory sarcoidosis]. Problemy tuberkuleza. 1995; (3): 34–37 (in Russian).Зубович Г.Л., Абрамовская А.К., Камышников В.С. и др. Показатели гомеостаза у больных саркоидозом органов дыхания. Пульмонология. 1996; (2): 50–54. Доступно на: https://journal.pulmonology.ru/pulm/article/view/3430/2817Zubovich G.L., Abramovskaya A.K., Kamyshnikov V.S. et al. [Homeostatic indices in pulmonary sarcoidosis]. Pul’monologiya. 1996; (2): 50–54. Available at: https://journal.pulmonology.ru/pulm/article/view/3430/2817 (in Russian).Drent M., Cremers J.P., Jansen T.L., Baughman R.P. Practical eminence and experiencebased recommendations for use of TNF-alpha inhibitors in sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2014; 31 (2): 91–107. Available at: https://www.wasog.org/dynamic/media/78/documents/2014_Drent_et_al_Sarcoidosis_anti-TNF.pdfDrent M., Cremers J.P., Jansen T.L., Baughman R.P. Practical eminence and experiencebased recommendations for use of TNF-alpha inhibitors in sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2014; 31 (2): 91–107. Available at: https://www.wasog.org/dynamic/media/78/documents/2014_Drent_et_al_Sarcoidosis_anti-TNF.pdfSimonini G., Taddio A., Cattalini M. et al. Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab. Arthritis Care Res. (Hoboken). 2011; 63 (4): 612–618. DOI: 10.1002/acr.20404.Simonini G., Taddio A., Cattalini M. et al. Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab. Arthritis Care Res. (Hoboken). 2011; 63 (4): 612–618. DOI: 10.1002/acr.20404.Orandi A.B., Eutsler E., Ferguson C. et al. Sarcoidosis presenting as granulomatous myositis in a 16-year-old adolescent. Pediatr. Rheumatol. Online J. 2016; 14 (1): 59. DOI: 10.1186/s12969-016-0121-5.Orandi A.B., Eutsler E., Ferguson C. et al. Sarcoidosis presenting as granulomatous myositis in a 16-year-old adolescent. Pediatr. Rheumatol. Online J. 2016; 14 (1): 59. DOI: 10.1186/s12969-016-0121-5.Judson M.A., Baughman R.P., Costabel U. et al. Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis. Eur. Respir. J. 2014; 44 (5): 1296–1307. DOI: 10.1183/09031936.00000914.Judson M.A., Baughman R.P., Costabel U. et al. Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis. Eur. Respir. J. 2014; 44 (5): 1296–1307. DOI: 10.1183/09031936.00000914.Utz J.P., Limper A.H., Kalra S. et al. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest. 2003; 124 (1): 177–185. DOI: 10.1378/chest.124.1.177.Utz J.P., Limper A.H., Kalra S. et al. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest. 2003; 124 (1): 177–185. DOI: 10.1378/chest.124.1.177.Majjad A., Bezza A., Biyi A. et al. Pulmonary sarcoidosis following etanercept treatment for ankylosing spondylitis: a case report and review of the literature. Case Rep. Rheumatol. 2018; 2018: 9867248. DOI: 10.1155/2018/9867248.Majjad A., Bezza A., Biyi A. et al. Pulmonary sarcoidosis following etanercept treatment for ankylosing spondylitis: a case report and review of the literature. Case Rep. Rheumatol. 2018; 2018: 9867248. DOI: 10.1155/2018/9867248.Kim T.K., Kang S.H., Moon H.S. et al. Pulmonary sarcoidosis that developed during the treatment of a patient with Crohn disease by using infliximab. Ann. Coloproctol. 2017; 33 (2): 74–77. DOI: 10.3393/ac.2017.33.2.74.Kim T.K., Kang S.H., Moon H.S. et al. Pulmonary sarcoidosis that developed during the treatment of a patient with Crohn disease by using infliximab. Ann. Coloproctol. 2017; 33 (2): 74–77. DOI: 10.3393/ac.2017.33.2.74.Инструкция по медицинскому применению лекарственного препарата Варгатеф®. Дата утверждения МЗ РФ 10.07.20. Доступно на: https://www.boehringer-ingelheim.ru/sites/ru/files/files/vargatef_pil_10-07-2020.pdfInstructions for the medical preparation Vargatef. Approval date of the Ministry Health of the Russian Federation July 10, 2020. Available at: https://www.boehringer-ingelheim.ru/sites/ru/files/files/vargatef_pil_10-07-2020.pdf (in Russian).Flaherty K.R., Wells A. U., Cottin V. et al. Nintedanib in progressive fibrosing interstitial lung diseases. N. Engl. J. Med. 2019; 381 (18): 1718–1727. DOI: 10.1056/NEJMoa1908681.Flaherty K.R., Wells A. U., Cottin V. et al. Nintedanib in progressive fibrosing interstitial lung diseases. N. Engl. J. Med. 2019; 381 (18): 1718–1727. DOI: 10.1056/NEJMoa1908681.Шмелёв Е.И. Саркоидоз. Пульмонология и аллергология. 2004; 13 (2): 3–10. Доступно на: https://atmosphere-ph.ru/modules/Magazines/articles/pulmo/ap_2_2004_03.pdfShmelev E.I. [Sarcoidosis]. Pul’monologiya i allergologiya. 2004; 13 (2): 3–10. Available at: https://atmosphere-ph.ru/modules/Magazines/articles/pulmo/ap_2_2004_03.pdf (in Russian).Романов В.В. Экстракорпоральные методы в лечении больных саркоидозом. Проблемы туберкулеза. 2001; (3): 45–49.Romanov V.V. Extracorporeal methods in the treatment of patients with sarcoidosis. Problemy tuberkuleza. 2001; (3): 45–49 (in Russian).Баранова О.П., Бакланова О.Э., Войнов В.А., Карчевский К.С. Применение плазмафереза в комплексном лечении больных саркоидозом легких. В кн.: Чучалин А.Г., ред. XIX Национальный Конгресс по болезням органов дыхания: cборник трудов. М.: ДизайнПресс, 2009: 215.Baranova O.P., Baklanova O.E., Voinov V.A., Karchevsky K.S. [The use of plasmapheresis in the complex treatment of patients with pulmonary sarcoidosis]. In: Chuchalin A.G., ed. [XIX National Congress on respiratory diseases: collection of works]. Moscow: DesignPress, 2009: 215 (in Russian).Смелая Т.В., Сивцевич Н.Н., Жолобов И.М. Экстракорпоральная фармакотерапия при лечении пациентов с различной нозологией. Медицинский вестник МВД. 2017; 91 (6): 44–50.Smelaya T.V., Sivtsevich N.N., Zholobov I.M. [Extracorporeal pharmacotherapy for treatment of patients with various nosologies]. Meditsinskiy vestnik MVD. 2017; 91 (6): 44–50 (in Russian).Taimeh Z., Hertz M.I., Shumway S., Pritzker M. Lung transplantation for pulmonary sarcoidosis. Twenty-five years of experience in the USA. Thorax. 2016; 71 (4): 378–379. DOI: 10.1136/thorax-jnl-2015-207497.Taimeh Z., Hertz M.I., Shumway S., Pritzker M. Lung transplantation for pulmonary sarcoidosis. Twenty-five years of experience in the USA. Thorax. 2016; 71 (4): 378–379. DOI: 10.1136/thorax-jnl-2015-207497.Salamo O., Roghaee S., Schweitzer M.D. et al. White donor, younger donor and double lung transplant are associated with better survival in sarcoidosis patients. Sci. Rep. 2018; 8 (1): 6968. DOI: 10.1038/s41598-018-25144-x.Salamo O., Roghaee S., Schweitzer M.D. et al. White donor, younger donor and double lung transplant are associated with better survival in sarcoidosis patients. Sci. Rep. 2018; 8 (1): 6968. DOI: 10.1038/s41598-018-25144-x.Meyer K.C. Lung transplantation for pulmonary sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2019; 36 (2): 92–107. DOI: 10.36141/svdld.v36i2.7163.Meyer K.C. Lung transplantation for pulmonary sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2019; 36 (2): 92–107. DOI: 10.36141/svdld.v36i2.7163.Rosenthal D.G., Anderson M.E., Petek B.J. et al. Invasive hemodynamics and rejection rates in patients with cardiac sarcoidosis after heart transplantation. Can. J. Cardiol. 2018; 34 (8): 978–982. DOI: 10.1016/j.cjca.2018.03.021.Rosenthal D.G., Anderson M.E., Petek B.J. et al. Invasive hemodynamics and rejection rates in patients with cardiac sarcoidosis after heart transplantation. Can. J. Cardiol. 2018; 34 (8): 978–982. DOI: 10.1016/j.cjca.2018.03.021.Sawahata M., Shijubo N., Johkoh T. et al. Progression of central-peripheral band and traction bronchiectasis clusters leading to chronic respiratory failure in a patient with fibrotic pulmonary sarcoidosis. Intern. Med. 2021; 60 (1): 111–116. DOI: 10.2169/internalmedicine.4862-20.Sawahata M., Shijubo N., Johkoh T. et al. Progression of central-peripheral band and traction bronchiectasis clusters leading to chronic respiratory failure in a patient with fibrotic pulmonary sarcoidosis. Intern. Med. 2021; 60 (1): 111–116. DOI: 10.2169/internalmedicine.4862-20.Faverio P., De Giacomi F., Sardella L. et al. Management of acute respiratory failure in interstitial lung diseases: overview and clinical insights. BMC Pulm. Med. 2018; 18 (1): 1–13. DOI: 10.1186/s12890-018-0643-3.Faverio P., De Giacomi F., Sardella L. et al. Management of acute respiratory failure in interstitial lung diseases: overview and clinical insights. BMC Pulm. Med. 2018; 18 (1): 1–13. DOI: 10.1186/s12890-018-0643-3.Авдеев С.Н. Легочная гипертензия при саркоидозе. Пульмонология. 2016; 26 (6): 725–735. DOI: 10.18093/0869-0189-2016-26-6-725-735.Avdeev S.N. [Pulmonary hypertension in sarcoidosis]. Pul’monologiya. 2016; 26 (6): 725–735. DOI: 10.18093/0869-0189-2016-26-6-725-735 (in Russian).Parikh K.S., Dahhan T., Nicholl L. et al. Clinical features and outcomes of patients with sarcoidosis-associated pulmonary hypertension. Sci. Rep. 2019; 9 (1): 4061. DOI: 10.1038/s41598-019-40030-w.Parikh K.S., Dahhan T., Nicholl L. et al. Clinical features and outcomes of patients with sarcoidosis-associated pulmonary hypertension. Sci. Rep. 2019; 9 (1): 4061. DOI: 10.1038/s41598-019-40030-w.Corte T.J., Wells A.U., Nicholson A.G. et al. Pulmonary hypertension in sarcoidosis: a review. Respirology. 2011; 16 (1): 69–77. DOI: 10.1111/j.1440-1843.2010.01872.x.Corte T.J., Wells A.U., Nicholson A.G. et al. Pulmonary hypertension in sarcoidosis: a review. Respirology. 2011; 16 (1): 69–77. DOI: 10.1111/j.1440-1843.2010.01872.x.Бородина Г.Л. Разработка программы медицинской реабилитации пациентов с саркоидозом органов дыхания и оценка ее эффективности. Вестник современной клинической медицины. 2012; 5 (1): 11–20. Доступно на: http://vskmjournal.org/images/Files/Issues_Archive/2012/Issue_1/VSKM_2012_N_1_p11-20.pdfBorodina G.L. [Developing of medical rehabilitation program and evoluation of its efficiency in pulmonary sarcoidosis patients]. Vestnik sovremennoy klinicheskoy meditsiny. 2012; 5 (1): 11–20. Available at: http://vskmjournal.org/images/Files/Issues_Archive/2012/Issue_1/VSKM_2012_N_1_p11-20.pdf (in Russian).Niedoszytko P. [Rehabilitation of patients with sarcoidosis]. Pol. Merkur. Lekarski. 2018; 44 (261): 150–151. Available at: https://www.researchgate.net/publication/324129986_Rehabilitation_of_patients_with_sarcoidosisNiedoszytko P. [Rehabilitation of patients with sarcoidosis]. Pol. Merkur. Lekarski. 2018; 44 (261): 150–151. Available at: https://www.researchgate.net/publication/324129986_Rehabilitation_of_patients_with_sarcoidosisЧерников А.Ю. Об эффективности медицинской реабилитации больных саркоидозом в общей лечебной сети. Здравоохранение Российской Федерации. 2008; (4): 36–39.Chernikov A.Yu. [On the effectiveness of medical rehabilitation of patients with sarcoidosis in the general medical network]. Zdravookhranenie Rossiyskoy Federatsii. 2008; (4): 36–39 (in Russian).Черников А.Ю., Дауров Б.И. Эффективность диспансеризации больных саркоидозом в условиях общей лечебной сети. Проблемы туберкулtза и болезней лtгких. 2007; 84 (8): 3–5.Chernikov A.Yu., Daurov B.I. [Efficiency of clinical examination of patients with sarcoidosis in a general medical network]. Problemy tuberkulyoza i bolezney lyogkih. 2007; 84 (8): 3–5 (in Russian).Гармаш Ю.Ю. Основные принципы наблюдения за больными саркоидозом. Российский медицинский журнал. 2009; (1): 22–23.Garmash Yu.Yu. [Monitoring of patients with sarcoidosis: basic principles]. Rossiyskiy meditsinskiy zhurnal. 2009; (1): 22–23 (in Russian).

The authors declare that there are no conflicts of interest present.